[{"text": "Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality Applied Therapeutics Tue, Jan 21, 2025, 3:00 PM 5 Minuten Lesezeit In diesem Artikel: APLT -4.09% Applied Therapeutics Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industries NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Reena Thomas Colacot as Vice President and Head of Quality. Ms. Colacot joins Applied with over 25 years of quality leadership experience across the biopharmaceutical and medical device industries. In this newly created role, she will report directly to the executive leadership team and Executive Chairman, and will be responsible for overseeing all quality matters, including Good Manufacturing Practices, Good Laboratory Practices, and Good Clinical Practices. \u201cWe are pleased to welcome Reena to Applied and are confident that her wealth of experience as a leader across quality functions will support our mission of meeting the unmet needs of patients with rare diseases,\u201d said John H. Johnson, Executive Chairman of Applied Therapeutics. \u201cI am excited to join Applied and work alongside this talented management team. They share my commitment to the highest standards of quality and my dedication to improving the lives of patients,\u201d said Ms. Colacot. Ms. Colacot brings over 25 years of leadership experience across quality roles, most recently at Bellus Health, Inc., where she built and led the quality and compliance functions. Following the acquisition of Bellus Health by GSK plc in 2023, Ms. Colacot continued to provide quality oversight in support of the successful integration and knowledge transfer of Bellus Health\u2019s primary asset to GSK. Throughout her career, Ms. Colacot has led quality functions across clinical, research and development, commercial, and regulatory teams. Prior to Bellus Health, she served as Executive Director, Quality Assurance at Quotient Sciences and previously held leadership roles in quality assurance at the International AIDS Vaccine Initiative (IAVI), Antares Pharma Inc., McNeil Consumer Healthcare, and Laureate Pharma Inc/Purdue Biopharma. Ms. Colacot holds an M.S. in Quality Assurance and Regulatory Affairs from the Temple University School of Pharmacy and an M.S. in Biomedical Engineering from the University of Alabama at Birmingham. About Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. The Company\u2019s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Classic Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency and PMM2-congenital disorder glycosylation (CDG). Weiterlesen To learn more, please visit www.appliedtherapeutics.com. Forward-Looking Statements This press release contains \u201cforward-looking statements\u201d that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding the strategy, future operations, prospects, plans and objectives of management, including words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cintend,\u201d \u201cpredicts\u201d and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are forward-looking statements. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we, therefore cannot assure you that our plans, intentions, expectations or strategies will be attained or achieved. Such risks and uncertainties include, without limitation, (i) our plans to develop, market and commercialize our product candidates, (ii) the initiation, timing, progress and results of our current and future preclinical studies and clinical trials and our research and development programs, (iii) our ability to take advantage of expedited regulatory pathways for any of our product candidates, (iv) our estimates regarding expenses, future revenue, capital requirements and needs for additional financing, (v) our ability to successfully acquire or license additional product candidates on reasonable terms and advance product candidates into, and successfully complete, clinical studies, (vi) our ability to maintain and establish collaborations or obtain additional funding, (vii) our ability to obtain and timing of regulatory approval of our current and future product candidates, (viii) the anticipated indications for our product candidates, if approved, (ix) our expectations regarding the potential market size and the rate and degree of market acceptance of such product candidates, (x) our ability to fund our working capital requirements and expectations regarding the sufficiency of our capital resources, (xi) the implementation of our business model and strategic plans for our business and product candidates, (xii) our intellectual property position and the duration of our patent rights, (xiii) developments or disputes concerning our intellectual property or other proprietary rights, (xiv) our expectations regarding government and third-party payor coverage and reimbursement, (xv) our ability to compete in the markets we serve, (xvi) the impact of government laws and regulations and liabilities thereunder, (xvii) developments relating to our competitors and our industry, (xviii) our ability to achieve the anticipated benefits from the agreements entered into in connection with our partnership with Advanz Pharma and (xiv) other factors that may impact our financial results. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. Factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the U.S. Securities and Exchange Commission, including the \u201cRisk Factors\u201d contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise. Contacts Investors: Maeve Conneighton / Andrew Vulis (212) 600-1902 or appliedtherapeutics@argotpartners.com Media: media@appliedtherapeutics.com Kommentare anzeigen AGB und Datenschutzerkl\u00e4rung Privacy Dashboard Empfohlene Nachrichtenartikel", "symbol": "APLT", "date": "2025-01-21T12:00:00+00:00", "sentiment": {"score": 0.34251615684479475, "confidence": 0.35177263617515564, "probabilities": {"positive": 0.35177263617515564, "negative": 0.00925647933036089, "neutral": 0.6389709115028381}}, "embedding": [-0.09647512435913086, -0.21213123202323914, 0.026190996170043945, -0.07842815667390823, -0.08190570771694183, -0.07201723754405975, 0.0035425820387899876, 0.17714253067970276, 0.11779002845287323, 0.04022524878382683, -0.15094149112701416, 0.046325694769620895, 0.0743841603398323, 0.0452190563082695, -0.13875159621238708, -0.046101830899715424, 0.057185739278793335, 0.07399660348892212, -0.17219270765781403, 0.009435806423425674, -0.002410009503364563, -0.010167907923460007, 0.018471185117959976, 0.048670630902051926, -0.14670556783676147, -0.005788580514490604, -0.11794260144233704, -0.12331264466047287, -0.11342186480760574, -0.1097903773188591, -0.028554528951644897, 0.08397385478019714, 0.08559699356555939, -0.07085508108139038, -0.027488959953188896, 0.20408260822296143, -0.0464119128882885, 0.06763072311878204, -0.04748351126909256, -0.08281151950359344, -0.05713077262043953, -0.06685278564691544, -0.09806802868843079, 0.044604070484638214, 0.07563324272632599, -0.2366199642419815, -0.02015620283782482, -0.03326605260372162, 0.030867625027894974, 0.0679183155298233, -0.10764835774898529, -0.048583269119262695, -0.04143046215176582, -0.034054096788167953, -0.025931410491466522, 0.059838734567165375, -0.033252306282520294, -0.11032894998788834, -0.012911111116409302, 0.10158675163984299, -0.05076158419251442, 0.0064851148054003716, 0.00373658025637269, 0.0440390482544899, 0.08954910188913345, -0.06480405479669571, -0.045061223208904266, -0.023569796234369278, -0.053516685962677, -0.12257246673107147, 0.13075841963291168, -0.08464299142360687, -0.09987591207027435, 0.08627261966466904, -0.011895131319761276, 0.16696614027023315, 0.059313662350177765, 0.12381219863891602, 0.06608637422323227, 0.04704006761312485, 0.170293390750885, 0.016890782862901688, 0.047103963792324066, 0.12814143300056458, 0.016370393335819244, -0.042552754282951355, -0.03497833386063576, -0.01639721728861332, -0.07832947373390198, 0.055000968277454376, 0.14309418201446533, 0.06946086883544922, 0.031130224466323853, -0.0024933302775025368, 0.014109889045357704, -0.019692085683345795, -0.07222695648670197, -0.040992312133312225, 0.06519599258899689, 0.08115088939666748, -0.14844152331352234, -0.024729810655117035, -0.1124749407172203, -0.051321446895599365, -0.0552222803235054, -0.11105976998806, 0.04403690621256828, -0.051303472369909286, 0.09189046919345856, 0.009088696911931038, -0.035750873386859894, 0.012648111209273338, -0.013489728793501854, -0.03472118824720383, -0.008254444226622581, 0.06685102730989456, -0.17490220069885254, -0.001550199929624796, 0.05723718926310539, -0.1363367736339569, 0.04427351802587509, 0.038621507585048676, -0.09152844548225403, -0.13761386275291443, 0.05780458822846413, 0.020601656287908554, 0.06438542902469635, 9.316542107915278e-33, 0.006554342806339264, 0.09234044700860977, 0.12923507392406464, 0.0929466038942337, -0.00019446900114417076, 0.08272874355316162, 0.09974876046180725, -0.05413041636347771, -0.035056471824645996, -0.08566533029079437, -0.08417722582817078, 0.07829617708921432, -0.08256322890520096, 0.014933395199477673, -0.12982337176799774, -0.08717617392539978, -0.01967781037092209, -0.01779186725616455, -0.13241934776306152, 0.044333960860967636, -0.01212272234261036, 0.020298924297094345, -0.09379185736179352, 0.10316683351993561, 0.04397977888584137, 0.03186305612325668, -0.09300480037927628, 0.051146499812603, 0.0862266793847084, 0.06157843396067619, -0.07162833213806152, 0.09968575090169907, -0.014115599915385246, -0.07100092619657516, -0.014087101444602013, -0.09359532594680786, -0.06215928867459297, -0.14508971571922302, 0.06050466373562813, 0.006914254277944565, -0.024510357528924942, 0.14174143970012665, -0.057927750051021576, -0.04602009057998657, -0.031028548255562782, -0.02471674606204033, 0.009909743443131447, 0.02314784564077854, 0.060628026723861694, -0.05662769079208374, -0.0577852800488472, 0.06755144894123077, 0.177018940448761, -0.002260827459394932, -0.007370500825345516, -0.007931704632937908, -0.006542290095239878, 0.0668681263923645, 0.08306725323200226, 0.1028825044631958, 0.009713584557175636, 0.15482644736766815, -0.14045555889606476, 0.08418989181518555, -0.006527511402964592, 0.01433261763304472, -0.06929778307676315, -0.06885528564453125, 0.07098285853862762, -0.008257483132183552, 0.020491786301136017, 0.09849601984024048, -0.0795462429523468, -0.02168109081685543, -0.02370404452085495, -0.07687875628471375, 0.06794461607933044, 0.14896820485591888, -0.033673353493213654, -0.02833445556461811, -0.03607838600873947, 0.08483938872814178, -0.06289921700954437, 0.024103783071041107, 0.03572584688663483, -0.06631872057914734, 0.02811242640018463, -0.0258930753916502, -0.018917009234428406, 0.011580167338252068, -0.004624595865607262, 0.01711336337029934, 0.03915660083293915, 0.1997540295124054, -0.08920183032751083, -1.0917271540147528e-32, 0.008446209132671356, -0.03857923299074173, 0.10108548402786255, -0.035288307815790176, 0.03964235633611679, 0.05125660076737404, -0.006101540289819241, -0.08384518325328827, 0.16840413212776184, -0.08350486308336258, 0.06076878309249878, 0.12554964423179626, 0.030724290758371353, -0.011850777082145214, -0.13349971175193787, 0.16228488087654114, -0.021802755072712898, -0.08015903830528259, -0.17147301137447357, -0.05544359236955643, -0.004571468103677034, 0.25207388401031494, -0.012587693519890308, 0.004284361843019724, 0.015409182757139206, 0.043029747903347015, 0.013839276507496834, 0.07879127562046051, 0.0809350460767746, -0.06636404246091843, 0.0016673337668180466, -0.054184138774871826, -0.22845375537872314, 0.01744063012301922, -0.023458212614059448, -0.043064847588539124, 0.1885085105895996, -0.09550022333860397, 0.03438953310251236, 0.020876752212643623, 0.13240119814872742, -0.021263252943754196, -0.002853870391845703, -0.004841282963752747, 0.11452534794807434, -0.03137147054076195, 0.019899126142263412, -0.08961421996355057, -0.01817626692354679, -0.011224968358874321, -0.07366418093442917, -0.018564149737358093, -0.045452311635017395, 0.10934579372406006, 0.07455455511808395, -0.07009387761354446, 0.02765120565891266, -0.06818558275699615, 0.014433241449296474, -0.10300904512405396, 0.052900876849889755, 0.049670808017253876, -0.01287741307169199, -0.025748977437615395, 0.049408867955207825, 0.12713900208473206, 0.13871179521083832, 0.010928697884082794, 0.005947485100477934, -0.11651155352592468, -0.06931910663843155, -0.09877321124076843, -0.027975229546427727, -0.11557187139987946, -0.025278132408857346, 0.029586900025606155, -0.11673201620578766, -0.11277762055397034, -0.14329451322555542, 0.006520414259284735, 0.007414408028125763, -0.06068478524684906, -0.08369410037994385, -0.05287870764732361, 0.0785280093550682, 0.06644751131534576, 0.11123780161142349, -0.094783715903759, -0.036464873701334, 0.05979736149311066, -0.11323681473731995, -0.10478107631206512, 0.01785726472735405, 0.04646642506122589, 0.052359726279973984, -1.0083618207090694e-07, 0.09504906833171844, -0.01745922677218914, -0.004703264217823744, -0.06703296303749084, 0.07242241501808167, -0.10054107010364532, -0.12541833519935608, 0.02498636394739151, 0.07125302404165268, 0.15736106038093567, 0.026083888486027718, 0.07419489324092865, -0.14822474122047424, -0.1037953644990921, 0.11736875772476196, 0.07163732498884201, -0.09207753837108612, 0.17278116941452026, -0.054384104907512665, 0.02933322638273239, -0.03534283488988876, 0.09192703664302826, 0.032661259174346924, -0.050345856696367264, -0.03959294408559799, -0.10390700399875641, 0.06111589074134827, -0.1341237723827362, -0.08389809727668762, 0.004906931892037392, 0.022140972316265106, 0.06769391149282455, 0.04815821722149849, -0.015114699490368366, -0.09390181303024292, -0.12536704540252686, 0.00779329426586628, 0.03520122915506363, 0.0554705485701561, 0.06345614045858383, -0.021762177348136902, 0.08132892847061157, -0.01089327409863472, 0.06803406774997711, -0.06946508586406708, -0.09438803791999817, -0.05373825132846832, 0.11474204808473587, 0.06130455434322357, -0.055939748883247375, -0.012196192517876625, 0.05912921577692032, -0.006198557559400797, -0.06122570112347603, -0.009960153140127659, 0.09022976458072662, 0.04728049039840698, 0.009904773905873299, -0.02627263031899929, -0.07703788578510284, 0.06358801573514938, -0.09347228705883026, 0.19675981998443604, 0.0033698733896017075], "changes": {"1wk": -9.312975904434548}}, {"text": "Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media? Ali Hassan Wed, Jan 8, 2025, 3:50 PM 5 min read In This Article: APLT -4.09% ^RUT -1.28% ^GSPC -0.76% We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media . In this article, we are going to take a look at where Applied Therapeutics, Inc. (NASDAQ:APLT) stands against other penny stocks to buy according to the media. Small-Cap Stocks Outlook for 2025 On December 24, Global Advisors\u2019 managing partner, Tom Lee, shared his thoughts on the potential of small and mid-cap stocks in 2025. Lee pointed out that 2025 is going to be a good year for small and mid-cap stocks. Backed by interest rate cuts and the incoming administration, companies are going to be expansionary and feel confident about mergers, added Lee. Moreover, Lee has reiterated that small-cap stocks are trading at a discount with a medium P/E multiple of 10. In an interview with CNBC, Lee said: \u201cI think small caps could in the next couple of years outperform by more than 100%.\u201d New Street Advisors CEO Delano Saporu has similar thoughts and believes that small-cap stocks are well-positioned to outperform in 2025. The economy has shown resilience in 2024, especially the recovery in the last quarter has signaled a promising outlook for businesses. Donald Trump\u2019s win has already driven significant gains in small-cap stocks amid the growing enthusiasm around the potential easing of regulations on businesses. Small-cap stocks are conventionally focused on the domestic market, with less exposure to international trade compared to large-cap counterparts. Therefore, Trump\u2019s tariff policies will not have a major impact on small-cap stocks compared to large-cap stocks. If you are interested in exploring the best penny stocks to buy in 2025, you can visit the 10 Best Penny Stocks to Buy for 2025 . Heading into 2025, the US stock market will deliver a second consecutive year of impressive gains. The S&P 500 index surged more than 25% in 2024. Whereas, the tech-heavy Nasdaq 100 jumped up to 28%. The Russell 2000 index, which covers small-cap companies, soared more than 15% over the last year, while the Dow Jones U.S. Small-Cap Index has risen by 18%. Torsten Slok, economist at Apollo Global Management (APO) , released his 2025 economic outlook for the U.S. According to Slok, the U.S. economy will deliver strong results with no signs of major slowing in 2025. Slok added that interest rates will likely stay \u2018higher for longer\u2019 despite the Fed\u2019s current interest rate-cutting cycle. The US economy is expected to register GDP growth of 2.2% in 2025, signaling a modest growth, driven by less restrictive monetary policy, resilient consumer spending, and a steadying labor market. Story Continues \u200b\u200bYou can also visit and see 12 Cheap Chinese Stocks to Buy According to Hedge Funds . A portfolio manager monitoring the changing trends in the U.S. companies' securities. \u200b\u200b Our Methodology To compile our list of the best penny stocks to invest in according to the media, we gathered over 50 penny stocks from financial media websites on the internet. We then selected the top 12 penny stocks that were the most widely held by hedge funds, as of Q3 2024. The list is ranked in ascending order based on the number of hedge fund holders in each stock. Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter\u2019s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). Applied Therapeutics, Inc. (NASDAQ: APLT ) Share Price (As of January 3): $0.94 Number of Hedge Fund Holders: 24 Applied Therapeutics, Inc. (NASDAQ:APLT) is a clinical-stage biopharmaceutical firm that is focused on developing a pipeline of novel drug candidates to fight validated molecular targets in indications of high unmet medical need. Applied Therapeutics, Inc.\u2019s (NASDAQ:APLT) lead drug candidate, govorestat, recently received a rejection from the FDA, as the regulator spotted issues with the New Drug Application (NDA). Govorestat is being developed to cure patients suffering from central nervous system rare metabolic diseases such as Galactosemia, Sorbitol Dehydrogenase Deficiency, and PMM2-CDG. The company is set to review the potential causes of the FDA decline and submit the NDA by next year. Applied Therapeutics is also working on AT-001 for the treatment of fatal fibrosis of the heart and has completed the third phase trials. Applied Therapeutics, Inc. (NASDAQ:APLT) is yet to make a major development to inspire long-term confidence among investors. A notable number of hedge funds hold a stake in APLT as one key development can make a big move for the company. Overall, APLT ranks 4th on our list of Best Penny Stocks To Invest In According to Media. While we acknowledge the potential of APLT to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than APLT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock . Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2025-01-08T12:50:40+00:00", "sentiment": {"score": 0.9039947632700205, "confidence": 0.9184530377388, "probabilities": {"positive": 0.9184530377388, "negative": 0.014458274468779564, "neutral": 0.06708870083093643}}, "embedding": [-0.008700407110154629, -0.09616169333457947, 0.07520250976085663, 0.022845156490802765, 0.12546184659004211, 0.06725835800170898, 0.039044518023729324, 0.16162016987800598, -0.023328479379415512, 0.06284879148006439, -0.06180509924888611, 0.1598486602306366, -0.029269853606820107, -0.0004892321303486824, -0.073128342628479, 0.032739680260419846, 0.010181787423789501, -0.032729215919971466, -0.14775852859020233, 0.058745142072439194, -0.15261010825634003, -0.14360645413398743, 0.006320991087704897, -0.020734362304210663, -0.04177176207304001, -0.00998010579496622, -0.05487145110964775, -0.0655653104186058, -0.2113661915063858, -0.092913419008255, -0.0864696353673935, 0.04945569485425949, -0.014575104229152203, -0.048701055347919464, -0.13695532083511353, 0.08364534378051758, 0.00513922655954957, 0.1428062915802002, 0.2041260451078415, -0.08436672389507294, 0.06354239583015442, -0.12165972590446472, -0.10385525971651077, -0.059073254466056824, 0.03630812093615532, -0.14929652214050293, 0.00031696935184299946, -0.07758209109306335, -0.05116504430770874, -0.10575716942548752, -0.10822505503892899, 0.028232328593730927, 0.021317726001143456, -0.1002577692270279, -0.1824893355369568, 0.02071194164454937, -0.16441595554351807, -0.04554349184036255, 0.09926778078079224, 0.09386526048183441, 0.018818454816937447, -0.16642546653747559, 0.06848019361495972, 0.01106608472764492, 0.25520986318588257, 0.005459249019622803, 0.09810858219861984, -0.032916199415922165, -0.15170948207378387, 0.015541305765509605, 0.05949811637401581, -0.06097937747836113, -0.14887681603431702, 0.049090221524238586, -0.031892329454422, 0.013322916813194752, 0.04445105418562889, 0.13581734895706177, 0.12713152170181274, 0.11607374995946884, -0.054941460490226746, 0.037421129643917084, -0.11447616666555405, -0.14623227715492249, -0.22168883681297302, -0.010883459821343422, -0.05787348002195358, -0.05660397559404373, 0.022068267688155174, -0.08800935745239258, 0.09753920882940292, 0.027572210878133774, -0.06930899620056152, 0.08066796511411667, 0.05020315572619438, 0.04725868999958038, -0.0964517742395401, 0.002078462392091751, -0.04316824674606323, 0.027051396667957306, 0.21904566884040833, 0.14643818140029907, -0.0755009576678276, -0.07562273740768433, -0.01719401404261589, -0.1945064216852188, 0.09508666396141052, -0.16228705644607544, 0.0038492768071591854, -0.02128751203417778, -0.09852803498506546, 0.12978151440620422, -0.1781473606824875, -0.05515474081039429, -0.11213739216327667, 0.02660292573273182, -0.07420960068702698, -0.06699052453041077, 0.1293269246816635, 0.017279766499996185, -0.001051958417519927, 0.19437852501869202, -0.09151742607355118, -0.052423425018787384, 0.02492074854671955, 0.056613028049468994, -0.18120865523815155, 9.460789958440558e-33, 0.01599249616265297, 0.11972276866436005, -0.06325498968362808, 0.033582620322704315, -0.12939924001693726, 0.10144095122814178, 0.10349772870540619, -0.09528520703315735, -0.17579108476638794, -0.01809247024357319, -0.07844007760286331, 0.12938709557056427, -0.05945355445146561, -0.05079352855682373, 0.06327849626541138, -0.1560661792755127, 0.032345764338970184, 0.0440044179558754, -0.034099504351615906, -0.15140675008296967, -0.016328856348991394, 0.15386715531349182, -0.05463387817144394, 0.00856622215360403, 0.10459911078214645, 0.02555353194475174, 0.01380867138504982, -0.07334846258163452, 0.05538220703601837, 0.09024584293365479, -0.10771127045154572, 0.1648540496826172, -0.061603255569934845, -0.015071757137775421, -0.03355278819799423, -0.03065376728773117, -0.11959441006183624, 0.01399446651339531, 0.05060306936502457, -0.09581906348466873, -0.07011573016643524, 0.22874149680137634, -0.0943513810634613, 0.02125183679163456, 0.000337294302880764, 0.001068825600668788, 0.07695826888084412, 0.11486801505088806, -0.07138345390558243, -0.11311748623847961, -0.04374171793460846, 0.023970656096935272, -0.06628138571977615, -0.025605840608477592, 0.0020750430412590504, 0.024589013308286667, -0.014522234909236431, -0.17757555842399597, 0.00034186244010925293, 0.05207478627562523, 0.12074689567089081, 0.10608755052089691, -0.1376795470714569, 0.03914742171764374, -0.14428886771202087, 0.26448750495910645, 0.0594668835401535, 0.11080425977706909, -0.1161627247929573, 0.16343937814235687, 0.18090246617794037, -0.05967119708657265, 0.060290053486824036, 0.04186894744634628, 0.15799632668495178, -0.044184520840644836, 0.13458868861198425, 0.07040588557720184, 0.07184465229511261, 0.01584101840853691, 0.09405890107154846, -0.052392780780792236, 0.10158712416887283, 0.053988076746463776, -0.058805305510759354, -0.05032024532556534, 0.09808646887540817, 0.045394524931907654, 0.09923091530799866, -0.05769193172454834, 0.03868790715932846, -0.047148801386356354, 0.07544571161270142, 0.09882965683937073, -0.06023247912526131, -1.024003691854416e-32, -0.005433220416307449, -0.04257425665855408, 0.017113547772169113, 0.045167192816734314, -0.06428273767232895, -0.0356319360435009, 0.14524652063846588, 0.0017723387572914362, 0.007761791348457336, -0.07465004920959473, -0.03190416097640991, 0.0541386753320694, 0.025076720863580704, 0.061665259301662445, -0.1189885288476944, 0.01048886775970459, 0.04166639968752861, -0.09773102402687073, 0.08276455849409103, -0.08822085708379745, 0.09513306617736816, 0.11348920315504074, -0.10934507846832275, 0.21438732743263245, 0.0198198389261961, -0.056038036942481995, 0.016510993242263794, -0.04578753188252449, -0.07504226267337799, -0.08653044700622559, -0.17140112817287445, -0.06626188009977341, -0.023520709946751595, 0.15157122910022736, 0.004450802691280842, -0.04720302298665047, 0.0066663725301623344, -0.15909405052661896, -0.044109635055065155, 0.057652149349451065, 0.10147077590227127, -0.027974534779787064, 0.01961040310561657, -0.09132448583841324, 0.036439910531044006, 0.0025739306584000587, 0.05785459280014038, 0.06925496459007263, 0.12672024965286255, 0.09203213453292847, 0.010838359594345093, 0.10336053371429443, 0.013084875419735909, 0.05934649705886841, -0.11265119165182114, 0.08629915118217468, 0.031236831098794937, 0.039277445524930954, -0.07498526573181152, -0.005091505125164986, -0.09753143787384033, 0.08181009441614151, 0.09499494731426239, -0.007399674504995346, 0.00757855549454689, -0.0037535689771175385, -0.0722123384475708, -0.10295671224594116, -0.04371482506394386, -0.11984696984291077, 0.08296647667884827, -0.19690340757369995, 0.0790189802646637, -0.12793000042438507, -0.10928727686405182, 0.2121552675962448, 0.018288493156433105, -0.022649817168712616, -0.017456403002142906, 0.10930842906236649, -0.015320531092584133, 0.08801992237567902, 0.004484642297029495, -0.030273282900452614, 0.01921752840280533, 0.13617368042469025, 0.049615032970905304, -0.11838293820619583, -0.13791924715042114, 0.048436958342790604, -0.14324812591075897, -0.12399362027645111, 0.008867901749908924, 0.06254227459430695, -0.03274420648813248, -9.978465698168293e-08, 0.11073361337184906, -0.029811237007379532, -0.02575629949569702, 0.055318571627140045, 0.044147975742816925, 0.11571484804153442, -0.040399517863988876, -0.07757309079170227, 0.08660940080881119, 0.25811174511909485, 0.15227581560611725, 0.1103721484541893, -0.1864573061466217, 0.06324397772550583, -0.1447915881872177, 0.11204423755407333, -0.11195056140422821, -0.027638502418994904, 0.009133942425251007, 0.006314257625490427, -0.007416003383696079, 0.11585992574691772, 0.1664508879184723, 0.018015919253230095, 0.037550270557403564, -0.025452610105276108, -0.027193283662199974, 0.12509110569953918, -0.03216267004609108, 0.004850776866078377, -0.037763141095638275, -0.038385700434446335, -0.05635147914290428, -0.0530083067715168, 0.004145132377743721, 0.06364370882511139, 0.06951028108596802, 0.151544988155365, 0.05792829766869545, 0.12101773917675018, -0.023738348856568336, -0.10696098208427429, 0.003983353264629841, -0.032816529273986816, -0.013475253246724606, -0.1702842265367508, -0.15153460204601288, 0.01564035937190056, 0.19495177268981934, -0.05176883563399315, 0.016259806230664253, -0.03871428966522217, -0.03003215417265892, 0.018882397562265396, 0.08054272830486298, 0.09851137548685074, -0.08568741381168365, -0.019143246114253998, -0.23168179392814636, -0.012399057857692242, 0.005759380757808685, -0.13940975069999695, 0.027461428195238113, 0.18792197108268738], "changes": {"1wk": -11.845733329644304}}, {"text": "Here\u2019s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10 Laiba Immad Mon, Jan 6, 2025, 5:13 PM 6 min read In This Article: APLT -4.09% We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10 . In this article, we are going to take a look at where Applied Therapeutics, Inc. (NASDAQ:APLT) stands against the other diabetes stocks. Global Growth and Innovation in Diabetes Care: The Rise of Continuous Glucose Monitors and AI Integration About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average. Both the number of cases and the prevalence of diabetes have steadily increased during the last several decades. However, according to the International Diabetes Federation, there are currently 500 million people with diabetes globally, and that number is expected to rise by 25% by 2030 and 51% by 2045. The continuous glucose monitor (CGM) is one type of medical equipment used to help manage diabetes, including type 1 and type 2. It is now a rapidly growing segment of diabetic care devices, and the market has increased significantly in recent years. According to GlobalData, the demand for sophisticated diabetes care products, such as insulin pumps, pens, and continuous glucose monitoring (CGM) devices, was projected to be valued at $21.8 billion in 2023. According to GlobalData's forecasts, the market will grow at a compound annual growth rate (CAGR) of 6.34% to reach revenues of $33.4 billion by 2030. There are now 97 goods in the CGM category, according to the GlobalData marketed products database. Only a small number of these devices are implantable sensors; the majority are conventional CGMs. The GlobalData pipeline products database indicates that 133 goods are either approved or in the development stage. According to the data, this market niche is growing rapidly and is a center for cutting-edge new technologies such as implantable CGMs. AI is now being included in CGM technology. For instance, Roche unveiled Accu-Chek SmartGuide, a revolutionary predictive AI-powered CGM device. Roche Diabetes Care Chief Medical Officer Julien Boisdron described it as \u201ca solution more than a CGM\u201d at the introduction. He explained how the system, which includes a sensor and two algorithms, helps with prediction and data visualization. Rising Demand for GLP-1 Medications: Opportunities and Challenges in Diabetes and Obesity Treatment The management of diabetes and its related complications has entered a new era of opportunity. The combined issues of diabetes and obesity can be effectively treated with these innovative approaches. Glucagon-like peptide-1 (GLP-1) agonists are a class of medications used to treat type 2 diabetes mellitus (T2DM) and obesity. The GLP-1 market, which is driven equally by diabetes and obesity, is predicted to reach $100 billion by 2030. By this time, there could be 30 million GLP-1 users or around 9% of the US population. Story Continues According to the most recent KFF Health Tracking survey, 12% of adult Americans say they have used a GLP-1 medication at some point. In the past five years, 43% of GLP-1 prescription users had diabetes, and 22% of patients with obesity or overweight diagnoses also took the medication. Over the course of the past year, the percentage of adults who have heard \"a little\" or \"a lot\" about these medicines has climbed from 70% to 82%, while the percentage of adults who have heard \"a lot\" or \"a lot\" about them has increased from 19% to 32%. However, the rising demand for these weight-loss and diabetes drugs has created challenges. The National Pharmacy Association (NPA) warned of a possible \"explosion in the unlicensed sale of medication online.\" Semaglutides, marketed under the name Ozempic, assist people with type 2 diabetes in controlling their blood sugar levels. However, they are also frequently used to aid in weight loss in certain nations, such as the US, where they are marketed under the name Wegovy. NPA chairman Nick Kaye stated: \u201cPharmacists remain deeply concerned that the current medicine shortages crisis could lead to an explosion in the unlicensed sale of medication online.\u201d Our Methodology Our methodology involved identifying healthcare companies focused on diabetes treatment using a stock screener. From the resultant dataset, we selected those with stock prices under $10 and ranked them based on their share price as of the close of December 26. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). A researcher in a lab coat holding up a test tube filled with a glowing green liquid, symbolizing the clinical-stage biopharmaceutical company's research into cardiovascular disease treatments. Applied Therapeutics, Inc. (NASDAQ: APLT ) Share Price as of the Close of December 26: $0.88 Standing third on our list is Applied Therapeutics, Inc. (NASDAQ:APLT). It is a biopharmaceutical company focused on developing treatments for rare diseases, particularly those related to metabolic disorders. Its lead drug, govorestat (AT-007), targets Aldose Reductase Inhibitors (ARIs) to treat conditions like Galactosemia, SORD Deficiency, and PMM2-CDG. The company is also developing AT-001 for Diabetic Cardiomyopathy and Diabetic Peripheral Neuropathy, and AT-003 for Diabetic Retinopathy, addressing significant unmet needs in diabetes care. Applied Therapeutics, Inc. (NASDAQ:APLT) reported $122,000 in revenue for Q3 2024 which is a significant decrease from $10.66 million in the same period of 2023 due to a one-time licensing agreement. R&D expenses rose to $14.8 million which was driven by increased personnel costs and data storage for commercialization. G&A expenses increased to $15.0 million due to higher headcount. The net loss for Q3 was $68.6 million, compared to $42.4 million in Q3 2023, largely due to higher expenses and changes in warrant liabilities. As of September 30, 2024, the company had $98.9 million in cash, with a runway expected to last until 2026. Applied Therapeutics, Inc. (NASDAQ:APLT) is awaiting critical regulatory decisions, including the FDA's Priority Review for govorestat in Classic Galactosemia, with a PDUFA date of November 28, 2024, and an EMA decision expected in Q1 2025. An NDA submission for govorestat in SORD Deficiency is planned for early Q1 2025. Analysts hold a consensus Moderate Buy rating on the stock. The average price target for the stock is $4.50, with a high estimate of $8.00 and a low estimate of $1.50. The average price target indicates a 411.31% increase from the last price of $0.88. Overall APLT ranks 3rd on our list of the best diabetes stocks to buy under $10. While we acknowledge the potential of APLT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than APLT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2025-01-06T14:13:26+00:00", "sentiment": {"score": 0.2211693376302719, "confidence": 0.23141123354434967, "probabilities": {"positive": 0.23141123354434967, "negative": 0.010241895914077759, "neutral": 0.7583468556404114}}, "embedding": [-0.09576039761304855, -0.07002657651901245, -0.0765707790851593, -0.002817643340677023, -0.04130397364497185, -0.017406733706593513, 0.09808741509914398, 0.18674759566783905, 0.06830001622438431, 0.09304259717464447, -0.1332983523607254, 0.09050232172012329, -0.06500206142663956, 0.06634591519832611, -0.07845151424407959, -0.04242287576198578, 0.022696109488606453, -0.06995486468076706, -0.000499475747346878, 0.05166575312614441, 0.03554677963256836, -0.017145853489637375, 0.12966394424438477, 0.0576670803129673, -0.11933592706918716, -0.029878702014684677, -0.06725206971168518, -0.13911323249340057, -0.08590688556432724, -0.014709760434925556, -0.10230889916419983, 0.05165204405784607, 0.059262409806251526, 0.009953778237104416, -0.09274063259363174, 0.0690065398812294, -0.06314197182655334, -0.05117044597864151, -0.12994384765625, -0.1253214180469513, 0.08260130882263184, -0.0884004682302475, -0.06944122165441513, 0.03952869772911072, 0.08029770851135254, -0.09796833992004395, -0.06340008974075317, 0.05076740309596062, -0.008589647710323334, 0.1434473842382431, -0.10904981195926666, -0.04534680023789406, 0.11404244601726532, 0.020154306665062904, 0.04911492019891739, -0.04920133203268051, -0.1396353542804718, -0.07184551656246185, 0.030360450968146324, -0.027432775124907494, -0.029789697378873825, 0.030507277697324753, 0.008154550567269325, -0.012935716658830643, 0.03551232069730759, -0.025266185402870178, -0.028982561081647873, -0.004437481053173542, 0.0031358925625681877, -0.03146948665380478, -0.05776151269674301, -0.07880714535713196, 0.048112932592630386, 0.05576061084866524, 0.018752174451947212, 0.04324556142091751, 0.10702013224363327, 0.0069590783677995205, 0.10078746825456619, 0.005111508071422577, 0.10339505970478058, 0.02624639868736267, 0.13917939364910126, 0.018241439014673233, 0.005298244766891003, -0.018639206886291504, 0.08954460173845291, 0.08781518042087555, 0.026473071426153183, -0.1357925534248352, 0.02625333145260811, 0.07567675411701202, -0.12004853785037994, 0.03245510533452034, -0.07168896496295929, -0.057933259755373, -0.04716568812727928, -0.028744129464030266, 0.04485611617565155, 0.01671028696000576, 0.04286130517721176, 0.023623725399374962, 0.07652992010116577, 0.00980181060731411, -0.08777382969856262, -0.1039557158946991, -0.011583572253584862, 0.010413235053420067, 0.13120222091674805, 0.14150507748126984, -0.1274220198392868, 0.09218569099903107, -0.08515875041484833, -0.06831637024879456, -0.12506289780139923, 0.09624535590410233, -0.09946758300065994, -0.03867773711681366, 0.15624436736106873, 0.17331081628799438, -0.04313615709543228, -0.027828993275761604, -0.017529573291540146, -0.08492011576890945, 0.03646257519721985, 0.17419472336769104, -0.020223675295710564, 7.7828636081379e-33, -0.05075407773256302, -0.033524710685014725, 0.026336228474974632, -0.10401058942079544, -0.10416968166828156, 0.10955499112606049, 0.04327209293842316, 0.1180916577577591, 0.03631611913442612, -0.07684595882892609, -0.1825801134109497, 0.0999961569905281, -0.051542751491069794, 0.1731528341770172, 0.09617865085601807, -0.15337106585502625, 0.06480899453163147, 0.013112432323396206, 0.07179445028305054, -0.017548557370901108, -0.07064861059188843, 0.006197942420840263, 0.0660911351442337, 0.06986123323440552, 0.09721632301807404, 0.032798733562231064, -0.0357782356441021, 0.12862032651901245, 0.07372963428497314, 0.037255048751831055, 0.015073321759700775, 0.0834382176399231, 0.10152493417263031, -0.1335156410932541, -0.002111617708578706, -0.07536455243825912, -0.053259968757629395, -0.011406166478991508, 0.026216089725494385, -0.010336333885788918, -0.0036874432116746902, 0.08738499879837036, 0.06292199343442917, -0.09947580099105835, 0.045610908418893814, 0.0269888024777174, 0.0008895199280232191, -0.0013365577906370163, -0.022741438820958138, -0.007333134301006794, -0.12161079794168472, 0.061796851456165314, -0.06666610389947891, -0.0062569729052484035, 0.0678374171257019, 0.017184630036354065, -0.10769500583410263, -0.1420592963695526, 0.06960831582546234, 0.08700031042098999, -0.14212703704833984, 0.09826318174600601, -0.017442721873521805, -0.0017373315058648586, -0.06329118460416794, 0.10941343009471893, 0.012864689342677593, 0.037739839404821396, -0.10021381080150604, 0.049047283828258514, 0.0006181010976433754, -0.05722276121377945, -0.008171869441866875, -0.04258885607123375, 0.002375564072281122, 0.019615262746810913, 0.020127398893237114, -0.007601367309689522, -0.05483921244740486, -0.026154899969697, 0.005447602830827236, 0.04411362484097481, 0.0031187785789370537, 0.03927428275346756, 0.03453560546040535, 0.015967167913913727, -0.06400707364082336, 0.04657479375600815, -0.10427770018577576, -0.14606735110282898, -0.06493938714265823, 0.11580312252044678, -0.008269181475043297, 0.04374535754323006, -0.0518014058470726, -1.1224082912551837e-32, -0.021884284913539886, 0.014324337244033813, 0.013597912155091763, 0.0004900926724076271, 0.06949424743652344, -0.06149611622095108, 0.08991032838821411, -0.24323588609695435, 0.08367040008306503, 0.017407331615686417, -0.013570859096944332, 0.06269127130508423, 0.039587877690792084, 0.11023019999265671, -0.06319452822208405, 0.11486130952835083, -0.17950977385044098, -0.03989249840378761, -0.057051047682762146, -0.030981477349996567, 0.027794670313596725, 0.19194598495960236, -0.0926196426153183, 0.02293163165450096, -0.06906326115131378, 0.04074239730834961, -0.050874825567007065, 0.10366491228342056, 0.0461333766579628, -0.08588564395904541, -0.1008031815290451, -0.06249072030186653, -0.1085345596075058, 0.08919097483158112, -0.011162442155182362, -0.09643423557281494, -0.01717548258602619, -0.08925153315067291, 0.008909188210964203, -0.040130551904439926, 0.22451038658618927, 0.08889602869749069, -0.006253535859286785, -0.08876138925552368, 0.10994583368301392, -0.0060267141088843346, 0.010054166428744793, 0.015906084328889847, 0.022717440500855446, -0.06653811782598495, -0.12080277502536774, 0.022172540426254272, -0.025607183575630188, -0.036030761897563934, -0.14463099837303162, -0.0021111362148076296, 0.007393886800855398, 0.00092830799985677, -0.11320052295923233, -0.025158856064081192, 0.06411805003881454, 0.0021481746807694435, 0.03357531875371933, 0.06975721567869186, 0.06544481217861176, 0.015339061617851257, 0.2500132918357849, -0.06468047946691513, 0.05434005707502365, -0.07214128226041794, 0.019323868677020073, -0.007693203166127205, 0.001346137374639511, -0.10296149551868439, -0.08571064472198486, 0.0796145647764206, -0.049963369965553284, -0.07256929576396942, -0.04292505979537964, -0.09880571812391281, 0.08494824171066284, -0.05654025822877884, 0.08451013267040253, -0.054384924471378326, -0.02664485201239586, 0.004818364512175322, 0.003639352973550558, -0.14316749572753906, -0.03591442480683327, 0.12493917346000671, -0.16172266006469727, -0.00454983115196228, -0.07373720407485962, -0.02936379984021187, 0.03836086764931679, -1.0100703207172046e-07, 0.1275324821472168, 0.041415683925151825, 0.03224382549524307, 0.008186277002096176, 0.02618328668177128, -0.08128266036510468, -0.0492396354675293, 0.06548090279102325, 0.09373988211154938, 0.09643766283988953, 0.03440442681312561, 0.15529121458530426, -0.0964319109916687, -0.01199695747345686, -0.020349128171801567, 0.019662488251924515, -0.09420756995677948, 0.07926265150308609, -0.04011920094490051, 0.04331980273127556, -0.11472077667713165, 0.03876577690243721, -0.030964242294430733, -0.006498385686427355, 0.014233646914362907, -0.07202640920877457, 0.025491531938314438, -0.0027560293674468994, -0.03013255074620247, 0.022286701947450638, 0.019128605723381042, -0.013758387416601181, 0.23258629441261292, 0.08622348308563232, 0.031721897423267365, -0.12112775444984436, 0.0488739050924778, 0.02917642518877983, -0.045917194336652756, 0.05761589854955673, 0.06322252750396729, -0.08413221687078476, -0.06105619668960571, -0.03915775194764137, -0.047249685972929, -0.11990918219089508, -0.034706853330135345, -0.046371012926101685, 0.00973447598516941, 0.05719500780105591, -0.03920397534966469, -0.006294785067439079, -0.0678892433643341, -0.07127673923969269, 0.08143706619739532, -0.027260301634669304, -0.19494253396987915, -0.07070444524288177, -0.07772611081600189, 0.014094687066972256, 0.04109110310673714, -0.19705216586589813, 0.08116267621517181, 0.028488442301750183], "changes": {"1wk": -22.31121166761586}}, {"text": "PREMIUM William Blair Downgrades Applied Therapeutics to Market Perform From Outperform MT Newswires Mon, Dec 23, 2024, 3:11 PM In This Article: APLT -4.09% Applied Therapeutics (APLT) has an average rating of overweight and mean price target of $4.50, acco PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-23T12:11:40+00:00", "sentiment": {"score": 0.03597195912152529, "confidence": 0.05121655389666557, "probabilities": {"positive": 0.05121655389666557, "negative": 0.015244594775140285, "neutral": 0.9335387945175171}}, "embedding": [-0.03041653521358967, -0.12389332056045532, 0.03569827228784561, 0.09118551760911942, 0.028144771233201027, -0.01455625519156456, 0.08692620694637299, 0.16906429827213287, -0.03135724738240242, 0.026101956143975258, 0.0626920685172081, 0.08863919228315353, 0.045975033193826675, 0.03783142939209938, -0.0024355240166187286, 0.11653870344161987, 0.1890324503183365, -0.03289664164185524, -0.044105708599090576, 0.08704439550638199, -0.15479756891727448, 0.05651547759771347, 0.02245573326945305, 0.1494869589805603, 0.046417903155088425, -0.00803296733647585, -0.2073480635881424, -0.07881131023168564, 0.0025095161981880665, -0.08422239869832993, -0.12470555305480957, -0.06855230778455734, 0.13704565167427063, -0.061468761414289474, 0.02985549159348011, 0.014981276355683804, -0.0533701553940773, 0.06119916960597038, -0.18365788459777832, 0.01847204752266407, 0.044138941913843155, -0.12092571705579758, -0.16430005431175232, 0.08086682856082916, -0.06017940491437912, -0.12171468883752823, -0.010615497827529907, 0.008214524015784264, 0.04800514131784439, 0.23446375131607056, -0.03888660669326782, -0.043834567070007324, 0.04345690459012985, -0.12084714323282242, -0.1033935621380806, -0.15514041483402252, -0.20450346171855927, 0.014636329375207424, -0.13516047596931458, -0.017983177676796913, -0.09196637570858002, 0.0014203194295987487, -0.1744653433561325, 0.1224571242928505, 0.11235789954662323, 0.08537013828754425, 0.03161191567778587, -0.1073392704129219, 0.07162290811538696, -0.16034871339797974, -0.0006419631536118686, -0.10825219750404358, 0.1312284618616104, -0.013781372457742691, 0.10722394287586212, 0.13128605484962463, -0.0026844593230634928, -0.04376501962542534, 0.06229059025645256, 0.029867766425013542, 0.14327606558799744, -0.08683545142412186, -0.02670561708509922, 0.033902280032634735, 0.07576502859592438, -0.1481504887342453, 0.0024706574622541666, -0.0700504258275032, -0.008383085019886494, -0.04758986458182335, 0.22586849331855774, -0.08331608027219772, -0.06657636165618896, 0.13883094489574432, -0.06658395379781723, 0.07922178506851196, -0.16641025245189667, -0.06658731400966644, -0.10160499811172485, 0.05981000140309334, -0.046710215508937836, 0.022452985867857933, -0.18870997428894043, 0.0740957036614418, -0.02067415788769722, -0.32248654961586, 0.04431430250406265, 0.06533429771661758, 0.18838895857334137, 0.09917555749416351, -0.0526089146733284, 0.007560093887150288, 0.04487476125359535, -0.008149098604917526, -0.03322036191821098, 0.09069526195526123, -0.06563301384449005, -0.014129563234746456, 0.06574978679418564, 0.058181967586278915, -0.0326002798974514, 0.10391604900360107, -0.10139081627130508, 0.022273173555731773, -0.08605355024337769, -0.04397396743297577, -0.005476007238030434, 1.2072614244376875e-32, -0.016733834519982338, 0.01823260262608528, 0.10388536006212234, 0.03704570233821869, -0.046770866960287094, -0.016069984063506126, -0.01151683833450079, -0.1388276070356369, 0.010422755964100361, -0.1891435831785202, -0.09127570688724518, 0.13306741416454315, -0.018192866817116737, 0.19243571162223816, -0.07905960083007812, -0.0935315415263176, -0.01672959141433239, 0.13029296696186066, 0.15745505690574646, 0.054380081593990326, -0.045122887939214706, 0.0003574034490156919, -0.026954442262649536, 0.03381994739174843, -0.1513727754354477, 0.1899396926164627, 0.024988628923892975, 0.007304904982447624, 0.15008895099163055, 0.07673418521881104, -0.1672796756029129, 0.025929441675543785, -0.029792416840791702, -0.12520331144332886, -0.13811083137989044, 0.06793268024921417, -0.11557124555110931, -0.06880262494087219, 0.026614289730787277, -0.06121905520558357, -0.09812341630458832, 0.1081198900938034, -0.06838185340166092, 0.009872647002339363, 0.09469598531723022, 0.008108407258987427, -0.041334494948387146, -0.062459807842969894, -0.10166982561349869, -0.08158570528030396, -0.007118717767298222, 0.11430483311414719, -0.15540975332260132, 0.029910774901509285, -0.21169225871562958, 0.03135521337389946, -0.06958380341529846, 0.061303313821554184, 0.09027639031410217, -0.003712736302986741, 0.25967031717300415, 0.12376861274242401, 0.017539000138640404, -0.09229356795549393, -0.1445641815662384, 0.011545075103640556, -0.09243122488260269, -0.2414955198764801, -0.16173449158668518, 0.17599715292453766, 0.020778924226760864, 0.1091260239481926, -0.0046552331186831, 0.050243474543094635, 0.03228176385164261, -0.049213070422410965, 0.11096537113189697, 0.07467775791883469, 0.13668425381183624, 0.03439687192440033, -0.01500122994184494, 0.04727531597018242, 0.13520261645317078, 0.10299645364284515, -0.013722493313252926, -0.017533574253320694, 0.02014251798391342, -0.0010357348946854472, -0.0412609688937664, -0.00019072162103839219, 0.08635905385017395, 0.03188886493444443, -0.1751311719417572, 0.07027930021286011, 0.004216704051941633, -1.345987022907995e-32, -0.0370611846446991, -0.04079771041870117, 0.1651410162448883, 0.006380019709467888, -0.05902918800711632, -0.023641305044293404, -0.11873531341552734, 0.09528204798698425, 0.34963667392730713, 0.2662459909915924, 0.07909329235553741, -0.029756411910057068, -0.05104805901646614, 0.06802811473608017, 0.09660407900810242, 0.15355108678340912, 0.008468663319945335, 0.024409925565123558, -0.052479084581136703, 0.05510760843753815, -0.01662302203476429, 0.2585585117340088, 0.02991155907511711, 0.1323520988225937, 0.031075147911906242, -0.07754908502101898, 0.08247923105955124, 0.04932589828968048, 0.11585202068090439, -0.24370035529136658, -0.09165345132350922, -0.0031664285343140364, -0.17061011493206024, -0.014051932841539383, -0.20588906109333038, 0.028726568445563316, 0.08616586774587631, 0.015483223833143711, -0.12500442564487457, 0.01996431313455105, 0.17902472615242004, -0.07746099680662155, -0.08566102385520935, -0.13567784428596497, 0.1463157683610916, -0.07920312136411667, -0.009485404007136822, -0.03580193594098091, 0.15499041974544525, -0.03148161619901657, 0.017822131514549255, 0.03963099420070648, 0.05925789475440979, 0.09131581336259842, -0.05565841495990753, -0.14397408068180084, 0.022104483097791672, -0.08783961832523346, -0.09572312980890274, -0.05050390958786011, -0.007523746695369482, 0.19367274641990662, -0.16955305635929108, -0.023214906454086304, 0.02532174251973629, 0.21529927849769592, 0.1340746134519577, -0.16300174593925476, -0.13938650488853455, -0.021277403458952904, -0.00825941376388073, -0.17408201098442078, 0.04024764895439148, -0.19014985859394073, 0.10601590573787689, 0.07356837391853333, 0.0014203166356310248, 0.008610382676124573, -0.07274500280618668, -0.1052636131644249, -0.06592050939798355, -0.08317350596189499, 0.03822548687458038, -0.06645343452692032, 0.025171024724841118, -0.035901989787817, 0.100104920566082, 0.01994411088526249, -0.1484629511833191, 0.21646951138973236, -0.061032649129629135, -0.14392229914665222, -0.009491564705967903, -0.028366152197122574, 0.11121821403503418, -1.0040078990414258e-07, 0.06794976443052292, -0.030829735100269318, -0.0107271708548069, 0.05339285358786583, -0.00765847647562623, 0.13962475955486298, -0.0912722796201706, 0.14208707213401794, 0.02974342741072178, 0.06555897742509842, 0.0032193325459957123, -0.016268890351057053, -0.08146999031305313, -0.011078291572630405, -0.12016502022743225, 0.019359543919563293, -0.09320201724767685, 0.10491736978292465, -0.02043772302567959, -0.00740304309874773, -0.14875875413417816, 0.08011426031589508, 0.181563600897789, 0.009995008818805218, 0.008223914541304111, 0.08936242014169693, 0.08461171388626099, -0.0781802386045456, 0.028360316529870033, -0.052112728357315063, -0.023532317951321602, 0.06012708321213722, -0.03955069184303284, -0.1021072044968605, -0.0888141468167305, -0.045085418969392776, 0.11098818480968475, 0.02781699225306511, -0.04689468443393707, 0.29729416966438293, -0.07175532728433609, -0.12829291820526123, 0.05729307234287262, -0.0022807735949754715, 0.14940030872821808, 0.04007434472441673, -0.22895447909832, 0.017369236797094345, 0.12495817989110947, -0.068171925842762, 0.19558636844158173, -0.02944803610444069, 0.0591367743909359, -0.0870739296078682, -0.08115725964307785, -0.06257475912570953, 0.013237668201327324, -0.21187639236450195, -0.18905635178089142, -0.040305837988853455, 0.1445116102695465, -0.28436362743377686, 0.11268783360719681, 0.0181184820830822], "changes": {"1wk": -1.6147634176795218, "1mo": -24.45213568189846}}, {"text": "PREMIUM Applied Therapeutics Names John Johnson as Executive Chair, Les Funtleyder as Interim CEO MT Newswires Fri, Dec 20, 2024, 3:45 PM In This Article: APLT -4.09% Applied Therapeutics (APLT) said it appointed John Johnson as executive chairman and Chief Financial PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-20T12:45:34+00:00", "sentiment": {"score": 0.030912374146282673, "confidence": 0.045063454657793045, "probabilities": {"positive": 0.045063454657793045, "negative": 0.014151080511510372, "neutral": 0.9407855272293091}}, "embedding": [-0.14983022212982178, -0.152788907289505, 0.027783159166574478, 0.03899597376585007, 0.1395922750234604, -0.0009960042079910636, 0.08791648596525192, 0.10144168883562088, 0.108626589179039, 0.02577603980898857, 0.029101284220814705, 0.18704751133918762, 0.06348492950201035, -0.03443262353539467, 0.06567443162202835, 0.058383770287036896, 0.09348474442958832, 0.06711612641811371, 0.019219040870666504, -0.060985978692770004, -0.13959826529026031, -0.01923898048698902, -0.08982560783624649, -0.15164102613925934, 0.0322364941239357, -0.00859263725578785, -0.20216453075408936, -0.013195016421377659, 0.035107143223285675, -0.08124307543039322, 0.08186560869216919, -0.11554621160030365, 0.08565393835306168, -0.11135411262512207, 0.03173447400331497, 0.00012003736628685147, -0.20883500576019287, 0.009864285588264465, -0.02845020592212677, -0.010404380038380623, 0.055508408695459366, -0.1625545769929886, -0.050859685987234116, -0.04775204882025719, 0.006691329181194305, -0.1489276885986328, 0.0068022324703633785, -0.07505349814891815, -0.07992769032716751, 0.15021514892578125, -0.005675989668816328, -0.1844489872455597, 0.05133894830942154, -0.19280196726322174, -0.08133552223443985, -0.054786838591098785, -0.21945543587207794, -0.07185982167720795, -0.1323443055152893, -0.11324671655893326, -0.0814315527677536, 0.005414752755314112, -0.1443053036928177, 0.17430751025676727, 0.011934921145439148, 0.03667742758989334, 0.08305477350950241, -0.0034448185469955206, -0.001084421412087977, -0.1509845107793808, 0.04957738146185875, -0.015537125058472157, 0.03308095782995224, -0.0776294693350792, 0.07772195339202881, 0.15245434641838074, -0.010789639316499233, 0.21013174951076508, 0.0847090482711792, -0.060815270990133286, 0.18840380012989044, -0.05193400755524635, 0.0031534391455352306, 0.016106033697724342, -0.11220036447048187, 0.01810537464916706, -0.028229769319295883, -0.013107066042721272, -0.09500567615032196, -0.0006058202707208693, 0.20748640596866608, -0.1257099211215973, -0.055887866765260696, 0.08054174482822418, -0.18118353188037872, 0.03128410875797272, -0.1981806457042694, 0.027231497690081596, -0.14089825749397278, 0.09644825756549835, -0.15899434685707092, -0.03902581334114075, -0.14095059037208557, 0.05192385986447334, -0.01472149696201086, -0.216885045170784, -0.021376317366957664, 0.16998670995235443, 0.165708988904953, -0.06971331685781479, -0.08622527122497559, 0.054193802177906036, 0.020274875685572624, -0.08879439532756805, -0.1270846575498581, 0.08513804525136948, -0.18755437433719635, -0.06065966561436653, 0.20999623835086823, -0.058702923357486725, 0.1611548811197281, 0.15930767357349396, -0.09384860098361969, 0.04647192358970642, 0.029018763452768326, 0.17755790054798126, -0.02924378216266632, 1.1086811620998688e-32, 0.02073337323963642, 0.09507352858781815, 0.26476797461509705, 0.04139147326350212, 0.0379658006131649, 0.09009053558111191, 0.10645560175180435, -0.2742709219455719, -0.01975638046860695, -0.1252884566783905, -0.18720395863056183, 0.17528720200061798, 0.07304461300373077, -0.039790887385606766, -0.33900973200798035, -0.1489330530166626, -0.05603897571563721, 0.0803244560956955, 0.0065662371926009655, -0.01951180212199688, 0.11677677184343338, 0.060461852699518204, -0.051640838384628296, 0.08551742881536484, -0.03729185089468956, 0.17040292918682098, 0.04099775478243828, -0.055667679756879807, 0.19261106848716736, 0.15958097577095032, -0.23403337597846985, 0.02236635610461235, -0.07084343582391739, 0.02070297673344612, 0.12536998093128204, 0.06589643657207489, -0.029921868816018105, -0.11922565847635269, 0.03080776520073414, -0.12133817374706268, -0.011024788953363895, 0.04511042311787605, -0.09428827464580536, -0.0038065314292907715, -0.08778965473175049, -0.017070187255740166, -0.10183894634246826, -0.049484509974718094, 0.12348020076751709, -0.07760412991046906, -0.019049206748604774, 0.07257513701915741, 0.0038002771325409412, -0.025573432445526123, -0.06483364850282669, 0.02774670533835888, -0.03461691364645958, 0.10838132351636887, 0.1275767832994461, -0.0044464850798249245, 0.09796541929244995, 0.17679812014102936, -0.06407187879085541, 0.016605641692876816, -0.08458901196718216, 0.05035272240638733, -0.0366680882871151, -0.24446061253547668, 0.006901595275849104, 0.17042258381843567, 0.1497276872396469, 0.07308468967676163, 0.16329410672187805, 0.06504756957292557, -0.07294122129678726, 0.031536225229501724, -0.04818800091743469, 0.04701303690671921, 0.015513832680881023, 0.10718517750501633, 0.035514362156391144, -0.06923983991146088, 0.09401798993349075, 0.06666935235261917, 0.032878559082746506, -0.09267272055149078, -0.07955677062273026, 0.07025551050901413, 0.1102311834692955, 0.06038371101021767, -0.01825721561908722, 0.06951505690813065, -0.03414567932486534, 0.1953432708978653, -0.002346301916986704, -1.3624345398647006e-32, -0.027152014896273613, 0.007066082675009966, 0.1318260282278061, -0.056695837527513504, 0.04805677384138107, -0.025436343625187874, -0.16013319790363312, 0.03521357849240303, 0.24919669330120087, 0.07768326997756958, 0.18131773173809052, 0.11360972374677658, -0.09564612805843353, 0.012075045146048069, -0.04474731907248497, 0.11746140569448471, -0.03270181268453598, -0.06300056725740433, -0.14757393300533295, 0.07790936529636383, -0.00574446888640523, 0.21717099845409393, -0.05554945021867752, 0.2137267291545868, 0.13141116499900818, -0.10429953783750534, 0.15908892452716827, 0.13237465918064117, 0.01208930928260088, 0.007041594944894314, -0.20575843751430511, -0.052229464054107666, -0.2191462218761444, -0.007215687073767185, 0.0008763415389694273, -0.037302084267139435, 0.17103315889835358, 0.09475935995578766, -0.08148767799139023, -0.05322766304016113, 0.1881549060344696, -0.1485220044851303, 0.006345657166093588, 0.008398191072046757, 0.22566230595111847, -0.050197649747133255, -0.10226043313741684, -0.18994362652301788, 0.04851212352514267, -0.019257690757513046, -0.24469365179538727, 0.009576891548931599, 0.05887632444500923, 0.06085396558046341, 0.023203806951642036, 0.005069337319582701, 0.09444384276866913, -0.0141524663195014, 0.08142246305942535, 0.0064321160316467285, 0.03473315387964249, 0.1611107736825943, -0.060262084007263184, -0.10141150653362274, 0.07246240228414536, 0.15588656067848206, 0.07175586372613907, -0.14954914152622223, -0.025651494041085243, -0.07651185244321823, -0.046610791236162186, -0.21771875023841858, -0.17156091332435608, -0.16972486674785614, 0.057723741978406906, 0.14788047969341278, -0.051119156181812286, -0.04165635257959366, -0.20563991367816925, -0.001076424727216363, 0.010673408396542072, -0.17151084542274475, -0.05550721660256386, -0.058191634714603424, -0.036072853952646255, -0.015481664799153805, 0.1359996646642685, -0.10918829590082169, -0.0817338079214096, -0.038650158792734146, -0.006600305438041687, -0.23811936378479004, -0.03352798894047737, 0.058808181434869766, -0.01643950864672661, -1.0009782869246919e-07, -0.007604584097862244, -0.058913495391607285, -0.055535752326250076, 0.02487586997449398, 0.11906600743532181, -0.00182417465839535, -0.09900767356157303, -0.03172428905963898, 0.05030951648950577, 0.08576478809118271, 0.10452304035425186, 0.021914975717663765, 0.012974949553608894, -0.11902537196874619, 0.07070087641477585, -0.010960564017295837, -0.098116435110569, 0.19987542927265167, -0.07288482040166855, 0.03151611238718033, -0.11229779571294785, 0.1643032729625702, 0.22722311317920685, -0.13106746971607208, 0.06301014870405197, -0.047344911843538284, 0.08907552808523178, -0.07613539695739746, 0.13259147107601166, -0.04571047052741051, -0.10747648030519485, 0.13895292580127716, -0.1382552981376648, 0.06898244470357895, -0.14803852140903473, -0.03621393069624901, 0.11430171877145767, 0.032817743718624115, 0.027760084718465805, 0.23279573023319244, -0.13247904181480408, 0.02180488593876362, 0.1443871706724167, 0.033117130398750305, -0.051307328045368195, 0.1211002916097641, -0.10682244598865509, -0.033402521163225174, 0.1311955600976944, -0.1352640837430954, 0.06304043531417847, -0.013021850027143955, 0.03196672722697258, -0.06535414606332779, -0.041390061378479004, 0.0171746127307415, 0.10790586471557617, -0.019370289519429207, -0.20112144947052002, -0.1707800328731537, -0.042583074420690536, -0.15383224189281464, 0.1898406594991684, 0.014394210651516914], "changes": {"1wk": 0.7954578551132996, "1mo": -25.795454468485733}}, {"text": "APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA Zacks Equity Research Thu, Nov 28, 2024, 6:13 PM 4 min read In This Article: APLT -4.09% Applied Therapeutics APLT announced that the FDA has issued a Complete Response Letter (CRL) for the new drug application (NDA) seeking approval for APLT\u2019s lead candidate, govorestat, to treat classic galactosemia. The CRL stated that the FDA has reviewed the application and cannot approve the NDA in its current form due to deficiencies in the clinical study results submitted in support of the application. Applied Therapeutics is\u00a0evaluating the FDA's feedback. It intends to promptly request a meeting to discuss the requirements for a potential NDA resubmission or appeal of the decision, and appropriate next steps. Shares of the company tanked 77.3% in the after-market hours, following the disappointing news. APLT\u2019s govorestat (also known as AT-007) is a novel central nervous system penetrant ARI, which is currently being developed for three rare neurological diseases. The NDA for govorestat for the galactosemia indication was accepted by the FDA in late February under its Priority Review pathway. Year to date, shares of Applied Therapeutics have skyrocketed 155.8% against the industry\u2019s 7.8% decline. Zacks Investment Research Image Source: Zacks Investment Research Per APLT, clinical study results submitted in support of the govorestat NDA showed rapid and sustained reductions in galactitol upon treatment with the candidate, leading to meaningful clinical benefits for pediatric patients and a favorable safety profile. In the phase III ACTION-Galactosemia Kids study in children with galactosemia aged 2-17 years, govorestat improved daily activities, behavior, cognition, fine motor skills and tremor. It also significantly reduced plasma galactitol levels in adults and children with galactosemia. Additional studies provided strong efficacy and safety data across 185 classic galactosemia patients over three years. Per Applied Therapeutics, approximately 3,300 patients in the United States with 80-100 new births per year and approximately 4,400 patients in the EU with 120 new births per year suffer from galactosemia, a rare genetic metabolic disease. A regulatory filing for govorestat to treat classic galactosemia is also currently under review in the EU.\u00a0The company expects a decision by the EU regulatory body early in the first quarter of 2025. Other Programs in APLT\u2019s Clinical-Stage Pipeline Apart from thegalactosemia indication, Applied Therapeutics is currently evaluating govorestat for two other indications, namely sorbitol dehydrogenase (SORD) deficiency and phosphomannomutase 2 deficiency (PMM2-CDG). The company is gearing up to submit an NDA with the FDA for govorestat to treat the SORD indication early in the first quarter of 2025. Applied Therapeutics clarified that the review and potential approval of govorestat for treating SORD is independent of the ongoing review of govorestat for classic galactosemia. Story Continues Govorestat enjoys the Orphan Medicinal Product designation in the EU for both galactosemia and SORD deficiency indications. Govorestat has also received Orphan Drug designation from the FDA for the treatment of galactosemia, PMM2-CDG and SORD deficiency, Pediatric Rare Disease designation for galactosemia and PMM2-CDG and Fast Track designation for galactosemia. Besides govorestat, APLT\u2019s pipeline comprises two other investigational candidates \u2014 AT-001 is being studied for the treatment of diabetic cardiomyopathy, while AT-003 is being developed for diabetic retinopathy. Applied Therapeutics Inc. Price and Consensus Applied Therapeutics Inc. Price and Consensus Applied Therapeutics Inc. price-consensus-chart | Applied Therapeutics Inc. Quote Zacks Rank & Stocks to Consider Applied Therapeutics currently carries a Zacks Rank #4 (Sell). Some better-ranked pharma stocks are Allogene Therapeutics ALLO, Pfizer PFE and Gilead Sciences GILD, each carrying a Zacks Rank #2 (Buy) at present.\u00a0You can see the complete list of today\u2019s Zacks #1 Rank (Strong Buy) stocks here . Over the past 60 days, Allogene Therapeutics\u2019 estimates for loss per share have narrowed from $1.40 to $1.35 for 2024, and that for 2025 has narrowed from $1.46 to $1.34. ALLO shares have lost 21.5% year to date. Allogene Therapeutics\u2019 earnings beat estimates in three of the trailing four quarters and matched once, delivering an average surprise of 9.42%. Over the past 60 days, Pfizer\u2019s earnings estimates have risen from $2.62 to $2.91 per share for 2024, while that for 2025 has increased from $2.84 to $2.91. PFE shares have lost 10.6% year to date. Pfizer\u2019s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 74.50%. Over the past 60 days, Gilead Sciences\u2019 earnings estimates have risen from $3.79 to $4.32 per share for 2024 while that for 2025 has increased from $7.24 to $7.38. GILD shares have risen 12.8% year to date. Gilead Sciences\u2019 earnings beat estimates in three of the trailing four quarters and missed the same in one, delivering an average surprise of 15.46%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE) : Free Stock Analysis Report Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report Allogene Therapeutics, Inc. (ALLO) : Free Stock Analysis Report Applied Therapeutics Inc. (APLT) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-11-28T15:13:00+00:00", "sentiment": {"score": 0.6687948107719421, "confidence": 0.765740692615509, "probabilities": {"positive": 0.765740692615509, "negative": 0.0969458818435669, "neutral": 0.13731347024440765}}, "embedding": [-0.06488999724388123, -0.13901463150978088, -0.10308574140071869, -0.028339985758066177, -0.1308961808681488, -0.05254343897104263, -0.033014848828315735, 0.2470369040966034, 0.0793725997209549, 0.1043553501367569, -0.06888709962368011, 0.134818896651268, 0.022361386567354202, 0.08346874266862869, -0.07120317220687866, -0.002080027014017105, 0.1269950270652771, -0.04165611416101456, -0.07676496356725693, 0.05630721524357796, 0.14433205127716064, -0.02816018834710121, 0.059297703206539154, 0.10284700989723206, -0.10564069449901581, -0.015488122589886189, -0.135980024933815, -0.10267744958400726, -0.09201513230800629, -0.047736503183841705, 0.05834420025348663, 0.08539946377277374, 0.12508314847946167, -0.053350310772657394, 0.004190560430288315, -0.03039819747209549, -0.0788702666759491, 0.01934763789176941, -0.16835449635982513, -0.016922656446695328, -0.009320104494690895, -0.09468570351600647, -0.15013182163238525, 0.09564525634050369, -0.005018961615860462, -0.2071915566921234, -0.0737997442483902, 0.03246872499585152, -0.02878934144973755, 0.06623520702123642, -0.09063728153705597, -0.11499906331300735, 0.06547221541404724, 0.06983602792024612, 0.023528926074504852, -0.030319247394800186, -0.14331571757793427, -0.11747713387012482, -0.025550438091158867, -0.01908111572265625, -0.029842432588338852, 0.0549464151263237, -0.08027142286300659, -0.07097098231315613, 0.07567393034696579, 0.05380275100469589, 0.06306949257850647, -0.1797385811805725, 0.030428165569901466, -0.12535855174064636, 0.1462727040052414, -0.13705965876579285, 0.08870505541563034, 0.0001942124217748642, 0.004853098653256893, 0.11138291656970978, 0.05644819140434265, 0.058420319110155106, 0.09336431324481964, -0.11526653170585632, 0.08818124234676361, 0.02255554124712944, 0.005890292581170797, -0.023880520835518837, 0.1441372036933899, -0.03526661545038223, 0.005178255029022694, 0.18875931203365326, 0.028913773596286774, 0.008849112316966057, 0.13715767860412598, -0.016673127189278603, -0.020497728139162064, -0.005400262773036957, -0.030773799866437912, 0.04001104459166527, -0.09142057597637177, -0.07411585003137589, 0.04372822865843773, -0.026006260886788368, 0.028121061623096466, 0.0034009218215942383, -0.010156337171792984, 0.07590985298156738, -0.04644235968589783, 0.01484830304980278, 0.05459406226873398, -0.01811298355460167, 0.07401953637599945, 0.04202082008123398, -0.14677491784095764, 0.015182252041995525, 0.0225467998534441, 0.1131519079208374, -0.12642452120780945, 0.1596594750881195, -0.11688046157360077, 0.07729501277208328, 0.17867496609687805, 0.02230294793844223, 0.1043708473443985, -0.012746539898216724, -0.00015505589544773102, -0.08260408043861389, 0.12119477242231369, 0.12075863033533096, -0.058991819620132446, 1.197081129080788e-32, -0.055977266281843185, 0.07762806117534637, 0.007135662715882063, -0.05246904119849205, -0.09715743362903595, 0.021636469289660454, 0.0354582779109478, -0.04844213277101517, 0.09814655035734177, -0.1424899697303772, -0.1293092668056488, 0.026076510548591614, 0.05056005343794823, 0.11179112643003464, -0.12384269386529922, 0.011019675992429256, 0.018942207098007202, -0.019013211131095886, 0.012726379558444023, 0.0427040159702301, -0.021655062213540077, 0.06962975114583969, -0.051656611263751984, 0.013741392642259598, -0.020950937643647194, 0.16637153923511505, -0.10557159781455994, 0.1260240375995636, 0.13229934871196747, 0.09267579764127731, 0.03462774306535721, -0.04100792109966278, -0.0039643216878175735, -0.09765106439590454, -0.08528865873813629, -0.009458176791667938, 0.012527464888989925, -0.07371407747268677, 0.04512345418334007, 0.013944811187684536, -0.04340358078479767, 0.08624857664108276, -0.06547620892524719, 0.04825608432292938, 0.08671203255653381, -0.03224407508969307, -0.15874776244163513, 0.07190240919589996, -0.12090425193309784, -0.002863561036065221, -0.012496769428253174, 0.006790038198232651, -0.020822377875447273, -0.04516302049160004, -0.05763182044029236, 0.11883343756198883, -0.143011212348938, -0.04975510388612747, 0.14347118139266968, 0.04143467918038368, 0.10497494041919708, 0.01959233544766903, -0.021754076704382896, -0.05986730754375458, -0.007675866596400738, 0.10963048040866852, -0.015715405344963074, -0.0522330068051815, -0.14624175429344177, 0.06364569067955017, -0.05627471208572388, -0.02091485634446144, 0.1275450736284256, 0.11474163830280304, 0.08001118153333664, -0.1380620151758194, 0.21782857179641724, 0.16145944595336914, -0.04778749868273735, -0.09893731772899628, -0.003656418528407812, 0.03720132261514664, 0.007206886541098356, 0.11562241613864899, 0.04784920811653137, -0.0508580282330513, 0.019321314990520477, 0.08061069995164871, -0.17493881285190582, -0.05895452946424484, 0.09282157570123672, -0.007164505310356617, -0.01688491180539131, 0.1663045883178711, 0.017171606421470642, -1.1003685068612351e-32, -0.048073358833789825, -0.053846731781959534, 0.061392590403556824, -0.07300746440887451, -0.04139196127653122, 0.09720824658870697, 0.032567329704761505, -0.09836667776107788, 0.19960501790046692, -0.1573801040649414, 0.0699550062417984, 0.005116884596645832, -0.006928659975528717, -0.11557898670434952, -0.04202680289745331, 0.12644708156585693, -0.1030701994895935, 0.04662761092185974, -0.14123497903347015, 0.12136703729629517, 0.01855074241757393, 0.22938573360443115, -0.11611044406890869, 0.08538252115249634, 0.06513552367687225, -0.03491628170013428, 0.00014887936413288116, -0.01689428649842739, 0.040426112711429596, -0.030658692121505737, -0.03820553794503212, -0.005354220047593117, -0.2580726742744446, -0.05912567675113678, -0.10747525095939636, -0.10388334095478058, 0.06052238494157791, -0.112447589635849, -0.1776311993598938, 0.005172319244593382, 0.07646532356739044, 0.16164323687553406, 0.020897824317216873, 0.006558528169989586, 0.061962906271219254, 0.12190461903810501, 0.03770507872104645, -0.01984984800219536, 0.0799998939037323, -0.02079690247774124, 0.03922389820218086, -0.024069469422101974, -0.005463413894176483, 0.07524587213993073, 0.04444441571831703, -0.0400201678276062, 0.13518601655960083, -0.037425387650728226, -0.06746471673250198, -0.06067335978150368, -0.012235916219651699, 0.046020351350307465, -0.03647565841674805, -0.09780310839414597, 0.13917966187000275, 0.07602658867835999, 0.06440159678459167, 0.011970629915595055, 0.16145360469818115, -0.08101951330900192, -0.10475341975688934, -0.11174950003623962, -0.008451735600829124, -0.06604807078838348, 0.014137729071080685, 0.1495746374130249, -0.14160121977329254, -0.13948673009872437, -0.11293493211269379, -0.03393077105283737, 0.032823383808135986, 0.0038406674284487963, -0.05851733684539795, -0.05149819701910019, 0.026296822354197502, -0.0027244375087320805, 0.08909466117620468, -0.051046110689640045, 0.03042176179587841, -0.005796379409730434, -0.1293514221906662, -0.07105160504579544, -0.054972272366285324, 0.10576483607292175, 0.10270968079566956, -1.0029367558672675e-07, 0.15571634471416473, 0.028459032997488976, 0.00920921005308628, -0.054096318781375885, 0.04384180158376694, -0.08411438763141632, -0.09135520458221436, 0.07321193814277649, -0.04357209801673889, 0.06236351281404495, 0.03731320798397064, 0.15005120635032654, -0.1067325696349144, -0.013815282844007015, -0.16374781727790833, 0.021457893773913383, 0.0821937769651413, 0.10653603821992874, -0.03334088250994682, 0.010277073830366135, -0.12438392639160156, 0.04008021205663681, 0.04040922969579697, -0.046671584248542786, 0.07386957108974457, -0.08511141687631607, 0.12530288100242615, 0.046603962779045105, -0.0020855264738202095, -0.1601478010416031, -0.012778464704751968, -0.04630633443593979, 0.1286550909280777, 0.02233682945370674, -0.12674519419670105, -0.0686812475323677, 0.10595302283763885, 0.13653025031089783, 0.10632802546024323, 0.12868639826774597, 0.010930357500910759, -0.0473179817199707, 0.032366275787353516, -0.01766868308186531, -0.009625247679650784, -0.031677111983299255, -0.10881088674068451, -0.02522262930870056, 0.020203035324811935, 0.014369525015354156, -0.012922192923724651, -0.05542345345020294, -0.08281289786100388, -0.10703873634338379, -0.03006562404334545, 0.0631069466471672, -0.10515441000461578, -0.0999741405248642, -0.02271433360874653, -0.15755212306976318, 0.13294470310211182, -0.12567874789237976, 0.009311133064329624, 0.025218166410923004], "changes": {"1wk": -36.45320295399449, "1mo": -57.98029570246395}}, {"text": "PREMIUM RBC Cuts Price Target on Applied Therapeutics to $1.50 From $4, Keeps Sector Perform, Speculative Risk MT Newswires Fri, Dec 20, 2024, 3:40 PM In This Article: APLT -4.09% Applied Therapeutics (APLT) has an average rating of overweight and mean price target of $4.50, acco PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-20T12:40:10+00:00", "sentiment": {"score": 0.0544580165296793, "confidence": 0.07082245498895645, "probabilities": {"positive": 0.07082245498895645, "negative": 0.016364438459277153, "neutral": 0.9128130674362183}}, "embedding": [-0.1099248006939888, -0.1581844985485077, -0.13777896761894226, 0.17851635813713074, 0.06656533479690552, 0.009335421957075596, 0.09141366928815842, 0.205275297164917, 0.08701322227716446, 0.08770789206027985, -0.032625600695610046, 0.04335255175828934, 0.04791683331131935, -0.005119989160448313, 0.01128736324608326, 0.06829942762851715, 0.21330216526985168, -0.02898157201707363, -0.014612291939556599, 0.0649462565779686, -0.1627134531736374, 0.017338311299681664, 0.019602978602051735, 0.19309957325458527, 0.06355980038642883, -0.09337880462408066, -0.05626425892114639, -0.05368286743760109, 0.028063250705599785, -0.0957791656255722, -0.028233835473656654, -0.1393982470035553, 0.1382162719964981, -0.041363321244716644, 0.06989055126905441, -0.07013208419084549, -0.1331578940153122, 0.027410762384533882, -0.1677253395318985, -0.0157183725386858, 0.1100192442536354, -0.06879772990942001, -0.2940029203891754, 0.08917740732431412, -0.008783172816038132, -0.16027295589447021, -0.035136621445417404, 0.11978242546319962, 0.031139863654971123, 0.17901648581027985, -0.05791034176945686, -0.07422570139169693, -0.08999194204807281, -0.09430434554815292, -0.11750795692205429, -0.11621391028165817, -0.18732090294361115, -0.07423248142004013, -0.009141135029494762, 0.05540665611624718, -0.09448093175888062, -0.06583564728498459, -0.12931323051452637, 0.06832068413496017, 0.06631584465503693, 0.04805608466267586, 0.04558410495519638, -0.02716103009879589, 0.10354553908109665, -0.11198612302541733, 0.04380869120359421, -0.060811012983322144, 0.1292833685874939, -0.04019661992788315, 0.13229723274707794, 0.13810735940933228, 0.04834580048918724, -0.06767664849758148, 0.022249862551689148, -0.03001289628446102, 0.07337949424982071, -0.13938604295253754, -0.05094993859529495, 0.01756449230015278, 0.06429829448461533, -0.00676601892337203, 0.11978121101856232, -0.028169764205813408, -0.019433574751019478, -0.03987988084554672, 0.2517422139644623, -0.04376691207289696, 0.022329995408654213, -0.05050182715058327, -0.06057128682732582, -0.0034406152553856373, -0.16814446449279785, -0.07780337333679199, -0.06330808997154236, -0.01348866056650877, -0.010961480438709259, -0.04336118325591087, -0.1390133649110794, 0.10439198464155197, -0.033424343913793564, -0.3485685884952545, 0.04411822184920311, 0.1077323704957962, 0.14598208665847778, 0.11958365887403488, -0.07939543575048447, 0.07724225521087646, -0.002713120775297284, -0.06583058834075928, -0.12209011614322662, 0.16887333989143372, -0.04239274561405182, -0.15445683896541595, 0.13486160337924957, 0.06965132802724838, -0.04174276813864708, 0.05667232722043991, -0.07855184376239777, 0.06143695116043091, -0.06020393222570419, -0.09717665612697601, -0.07814432680606842, 1.3250045956826111e-32, -0.0192978847771883, 0.06543351709842682, 0.03779058903455734, -0.1268610954284668, -0.1586463898420334, 0.08174705505371094, -0.0203882846981287, -0.16968683898448944, 0.021770939230918884, -0.10927104204893112, -0.10354480147361755, 0.1492176651954651, 0.07367172837257385, 0.22213928401470184, -0.13295917212963104, -0.18684904277324677, -0.03998531773686409, 0.11873617768287659, 0.10464750975370407, 0.12824459373950958, -0.09992805868387222, -0.0556509792804718, -0.0681498646736145, 0.06451622396707535, -0.14749543368816376, 0.1809731423854828, -0.03224803879857063, -0.018606917932629585, 0.16323557496070862, 0.059218477457761765, -0.13813111186027527, 0.07415950298309326, 0.06279955059289932, -0.11175726354122162, -0.020426010712981224, 0.056160472333431244, -0.015554226003587246, -0.0018714056350290775, 0.009356514550745487, -0.07491010427474976, -0.07110362499952316, 0.08137932419776917, -0.12349477410316467, 0.021255185827612877, 0.1563277244567871, -0.07815787941217422, -0.06943726539611816, -0.00673040421679616, -0.16649481654167175, -0.09043364226818085, -0.11419269442558289, 0.12715360522270203, -0.04426218569278717, 0.11056454479694366, -0.13097670674324036, -0.0701262503862381, -0.10042738914489746, -0.0795033797621727, 0.1551206111907959, 0.05220121890306473, 0.2362169325351715, 0.16107167303562164, -0.006066419184207916, -0.06047981604933739, -0.1256636530160904, 0.07804770022630692, -0.1542932093143463, -0.15233314037322998, -0.09284769743680954, 0.1906738132238388, 0.1040443405508995, 0.1036846712231636, 0.10849206894636154, 0.06137527897953987, -0.01733255758881569, -0.03829168528318405, 0.05826152116060257, 0.08249303698539734, 0.11068980395793915, 0.02346562035381794, -0.050637923181056976, 0.031172489747405052, 0.15216298401355743, 0.06878765672445297, 0.011026321910321712, -0.03534657880663872, -0.06772574037313461, -0.017041712999343872, -0.2019580453634262, -0.06321810185909271, 0.08770770579576492, 0.056822098791599274, -0.16490912437438965, 0.11878606677055359, 0.07226253300905228, -1.3099075747982066e-32, 0.053219109773635864, 0.029639996588230133, 0.14319290220737457, 0.007594947703182697, 0.012060655280947685, -0.0333925224840641, -0.10385671257972717, 0.06720661371946335, 0.339608371257782, 0.21827958524227142, 0.03982082009315491, 0.08154023438692093, -0.11235745996236801, 0.12879912555217743, 0.0604974702000618, 0.048776306211948395, -0.04429406672716141, -0.012242516502737999, -0.05056251212954521, 0.06335336714982986, -0.18707382678985596, 0.25154373049736023, 0.04958895966410637, 0.18056632578372955, 0.07760343700647354, -0.03931824862957001, 0.04375837743282318, 0.04980788752436638, 0.07969029247760773, -0.15620143711566925, -0.18238386511802673, 0.008612404577434063, -0.17635256052017212, 0.024144964292645454, -0.20953992009162903, -0.009959598071873188, 0.1197248101234436, 0.11776714026927948, -0.06260401755571365, -0.04144987836480141, 0.16949710249900818, -0.05801567807793617, -0.15886308252811432, -0.11440367251634598, 0.17721283435821533, -0.08596792072057724, 0.05938088521361351, 0.09222744405269623, 0.10527631640434265, -0.03822185844182968, 0.0027484723832458258, -0.0541655495762825, 0.10597775131464005, 0.10168059170246124, -0.06257867068052292, -0.12989793717861176, 0.026913903653621674, -0.028547324240207672, -0.03383639082312584, -0.07984257489442825, 0.06863761693239212, 0.24529686570167542, -0.11588464677333832, -0.009647537022829056, 0.02237500250339508, 0.11428678035736084, 0.22448121011257172, -0.0856473445892334, -0.053302403539419174, -0.07453691959381104, -0.05027294531464577, -0.08233906328678131, 0.026198873296380043, -0.13078203797340393, 0.03023049235343933, 0.10868383198976517, -0.026438582688570023, 0.014854693785309792, -0.008015607483685017, -0.037717554718256, -0.03018908016383648, -0.07568351924419403, -0.027857057750225067, -0.04028238356113434, 0.021069958806037903, -0.017495794221758842, -8.500526018906385e-05, -0.008545905351638794, -0.09656298160552979, 0.17012985050678253, -0.1765669286251068, -0.10620079934597015, 0.02218293584883213, 0.019315823912620544, 0.011242267675697803, -1.0002574413192633e-07, 0.13587726652622223, 0.008200414478778839, 0.014096735045313835, 0.10448050498962402, 0.052786387503147125, 0.10354378819465637, -0.07945650070905685, 0.020353009924292564, 0.0072959004901349545, 0.1431773602962494, -0.013385686092078686, -0.0034095628652721643, -0.05515199154615402, -0.03265224024653435, -0.14564312994480133, 0.011754052713513374, -0.045793090015649796, 0.138151615858078, 0.017824912443757057, -0.044359009712934494, -0.1176031231880188, 0.1325339525938034, 0.15945634245872498, -0.05472575128078461, -0.01591319404542446, 0.0031061789486557245, -0.0012926820199936628, -0.06546188145875931, 0.060235317796468735, 0.0015726680867373943, 0.04069836065173149, 0.01300366036593914, 0.05723708122968674, -0.08718883246183395, -0.015471376478672028, -0.031360555440187454, 0.10613061487674713, 0.11152326315641403, -0.0540933720767498, 0.22906211018562317, -0.010648224502801895, -0.08784976601600647, 0.04139171913266182, -0.06539526581764221, 0.026196010410785675, 0.017148934304714203, -0.2576342523097992, -0.09651511162519455, 0.13249331712722778, -0.049374550580978394, 0.13609299063682556, -0.019518617540597916, 0.010552333667874336, -0.08114083856344223, -0.024821938946843147, -0.07494991272687912, 0.011683397926390171, -0.18079331517219543, -0.14140534400939941, 0.03502051904797554, 0.1151357963681221, -0.3265697658061981, 0.017453406006097794, 0.0927758738398552], "changes": {"1wk": 0.7954578551132996, "1mo": -25.795454468485733}}, {"text": "Applied Therapeutics Appoints John H. Johnson as Executive Chairman Applied Therapeutics Fri, Dec 20, 2024, 3:00 PM 11 min read In This Article: RVPH +5.29% RVPHW -4.04% VSTM -6.09% APLT -4.09% Applied Therapeutics Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the following leadership changes, effective immediately: John H. Johnson, a recognized leader in the pharmaceutical and biotechnology industry, has been named Executive Chairman; Dr. Shoshana Shendelman has stepped down as Chair and CEO; and Les Funtleyder, Applied Therapeutics\u2019 Chief Financial Officer, has been named Interim Chief Executive Officer. Mr. Johnson is a biopharmaceutical industry veteran with 40 years of transformational leadership experience at global healthcare organizations, including Johnson & Johnson, Eli Lilly & Company, ImClone, and Pfizer, Inc. He brings to Applied Therapeutics a multi-decade track record of implementing turnaround plans that enable growth and value creation for shareholders. He has served as the CEO of Reaction Biology and before that served as CEO of Strongbridge Biopharma plc prior to its acquisition by Xeris Biopharma Holdings. He is also an experienced Director having served on numerous boards across biotech and biopharmaceutical services companies. Dr.\u00a0Teena Lerner, Applied Therapeutics\u2019 Lead Independent Director, said, \u201cOn behalf of the Board, we strongly believe that John will be a tremendous addition to Applied Therapeutics. His experience leading pre-commercial businesses, deep knowledge of rare diseases and the commercialization process, along with his commitment to culture, are deeply aligned with Applied Therapeutics\u2019 priorities. We believe this change in leadership is the right next step for our Company, our shareholders and the patients we aim to serve.\u201d Dr. Lerner continued, \u201cLes has a strong understanding of our business and operations and has fostered relationships across our industry and the Applied Therapeutics team since resuming the role of CFO last year. Having served as a member of the Board since June 2016 and previously served as our interim CFO in 2018 and 2019, he brings to the interim CEO role deep knowledge of our company and extensive experience managing and investing in the healthcare industry. We are confident in Les and John\u2019s ability to drive the Company forward and will continue to support them and the leadership team while we work to identify a permanent CEO.\u201d Mr. Johnson said, \u201cI look forward to leveraging my background and years of biopharmaceutical experience to help write the next chapter for Applied Therapeutics. My top priority will be to ensure we have the right groundwork in place to work toward our regulatory and clinical milestones. I look forward to working closely with the Board, management and team to drive value creation.\u201d Story Continues \u201cI am honored to assume the role of Interim CEO and lead the Company forward,\u201d said Mr. Funtleyder, \u201cWe have a deep bench of talent throughout the organization and a promising clinical pipeline. Utilizing our unique multifaceted approach to drug development, I am confident in our potential to bring the candidates in our pipeline to the patients who need them.\u201d \u201cWe thank Shoshana for her leadership and vision, which have been pivotal to developing Applied Therapeutics\u2019 portfolio of highly specific and selective product candidates. We wish her the very best in her future endeavors,\u201d concluded Dr. Lerner. Dr. Shendelman said, \u201cFounding and leading Applied Therapeutics for the last eight years has been an incredible journey. Together, we completed multiple successful clinical trials, built commercial infrastructure and advanced the Company\u2019s Aldose Reductase Inhibitor (ARI) franchise across multiple disease areas.\u201d With the support of the Company's finance organization, Mr. Funtleyder will continue to serve as CFO while serving as Interim CEO. Business Updates As previously disclosed, in November 2024, the Company received a Complete Response Letter (\u201cCRL\u201d) for the New Drug Application (NDA) for govorestat for the treatment of Classic Galactosemia. Given the leadership changes announced today, the Company continues to evaluate its response to the CRL, including any meeting request to discuss appropriate next steps with FDA. Following receipt of the CRL, the Company also today announced the withdrawal of the Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for govorestat (AT-007) for the treatment of Classic Galactosemia, as more time is needed to acquire further data to support a European MAA. In light of recent regulatory developments, the Company will be closely examining the ongoing Sorbitol Dehydrogenase (SORD) Deficiency clinical development program and will continue to work with the FDA on the data needed to support an appropriate regulatory pathway for the drug, including ongoing work to provide the FDA with support for the potential use of the accelerated approval pathway for govorestat for the treatment of SORD Deficiency. To accommodate these ongoing workstreams, the Company currently expects to submit an NDA for govorestat for the treatment of SORD after the first quarter of 2025. Mr. Funtleyder continued, \u201cWhile we complete the important work to best position govorestat, we are focused on execution and ensuring the highest standards of integrity and quality. SORD Deficiency is a rare neuromuscular disease with no FDA-approved drugs, and it remains highly attractive in terms of unmet need, key opinion leader support and commercial potential.\u00a0We continue to believe in the clinical value of govorestat and remain committed to the prospect of providing patients with a treatment option that has the potential to slow disease progression.\u201d Additionally, the Company announced that the Compensation Committee of the Board of Directors of the Company approved inducement awards to Mr. Johnson under Nasdaq Listing Rule 5635(c)(4) consisting of a stock option award to acquire 2,000,000 shares of our common stock and a restricted stock unit award with respect to 1,000,000 shares of our common stock. Fifty percent of each of these inducement awards will vest upon the earlier to occur of a change in control or the approval by the United States Food and Drug Administration (FDA) of the Company\u2019s proposed new drug application relating to the treatment of Sorbitol Dehydrogenase Deficiency, with the remaining fifty percent of the inducement awards vesting in equal annual installments on each of the first two anniversaries of the grant date. Mr. Johnson must generally remain continuously employed through each vesting date. About John H. Johnson John H. Johnson, 66, is a recognized leader in the pharmaceutical and biotechnology industry, with more than four decades of experience. Currently, he serves as a member of the Board of Directors, member of the Compensation Committee and Chair of the Nominating and Corporate Governance Committee of Verastem, Inc. (Nasdaq: VSTM) since April of 2020. He has served as Chief Executive Officer and Board Director of Reaction Biology, since March of 2022, and a member of the Board of Directors of Xeris Biopharma Holdings, Inc. serving on the Nominating and Corporate Governance Committee and Axogen, Inc. serving on the compensation committee and chair of the Quality, Compliance, and Portfolio committee. He served from 2005-2007 as the Company Group Chairman of Biopharmaceuticals within Johnson & Johnson, responsible for the Biotechnology, Immunology, and Oncology commercial businesses. Previously, Mr. Johnson served from September 2009 to January 2011 as president of Eli Lilly & Company\u2019s Worldwide Oncology Unit, following the company\u2019s 2008 acquisition of ImClone Systems, Inc., where he served as Chief Executive Officer and a member of ImClone\u2019s Board of Directors from August 2007 until October 2008. He has served as a member of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA), from January 2013 until August 2014, and as a member of the Health Section Governing Board of biotechnology Industry Organization (BIO), from January 2013 to August 2014.\u00a0Mr. Johnson also served as CEO of Strongbridge Biopharma plc, a rare disease company, from July 2020 until its acquisition by Xeris Biopharma Holding Inc. in October 2021. About Les Funtleyder Les Funtleyder, 55, has served as a member of our board of directors since June 2016 and since November 2023 has served as our Chief Financial Officer. Mr. Funtleyder has served as a healthcare portfolio manager at E Squared Capital Management, LLC since January 2014, a role from which he is currently taking a sabbatical, as a senior external advisor with McKinsey and Co. since June 2017, and as a consulting partner at Bluecloud Health, a private equity healthcare fund, from December 2013 to April 2020. Mr. Funtleyder previously served as the director of strategic investments and communications of OPKO Health Inc., a publicly traded healthcare company. Mr. Funtleyder currently serves on the board of directors of several private healthcare companies and foundations while also serving on the board of directors of Nasdaq-listed Reviva Pharmaceuticals (Nasdaq: RVPH) and as an advisor at Zentynel Frontier Investments. Mr. Funtleyder is an adjunct professor at Columbia University Medical Center and an adjunct professor of healthcare investors at the Columbia University School of Public Health. Mr. Funtleyder received his B.A. from Tulane University and MPH from Columbia University Mailman School of Public Health. About Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. The Company\u2019s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Classic Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency and PMM2-congenital disorder glycosylation (CDG). To learn more, please visit www.appliedtherapeutics.com . Forward-Looking Statements This press release contains \u201cforward-looking statements\u201d that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding the strategy, future operations, prospects, plans and objectives of management, including words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cintend,\u201d \u201cpredicts\u201d and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are forward-looking statements. These include, without limitation, statements regarding the timing to submit an NDA for govorestat for the treatment of SORD. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we, therefore cannot assure you that our plans, intentions, expectations or strategies will be attained or achieved. Such risks and uncertainties include, without limitation, (i) our plans to develop, market and commercialize our product candidates, (ii) the initiation, timing, progress and results of our current and future preclinical studies and clinical trials and our research and development programs, (iii) our ability to take advantage of expedited regulatory pathways for any of our product candidates, (iv) our estimates regarding expenses, future revenue, capital requirements and needs for additional financing, (v) our ability to successfully acquire or license additional product candidates on reasonable terms and advance product candidates into, and successfully complete, clinical studies, (vi) our ability to maintain and establish collaborations or obtain additional funding, (vii) our ability to obtain and timing of regulatory approval of our current and future product candidates, (viii) the anticipated indications for our product candidates, if approved, (ix) our expectations regarding the potential market size and the rate and degree of market acceptance of such product candidates, (x) our ability to fund our working capital requirements and expectations regarding the sufficiency of our capital resources, (xi) the implementation of our business model and strategic plans for our business and product candidates, (xii) our intellectual property position and the duration of our patent rights, (xiii) developments or disputes concerning our intellectual property or other proprietary rights, (xiv) our expectations regarding government and third-party payor coverage and reimbursement, (xv) our ability to compete in the markets we serve, (xvi) the impact of government laws and regulations and liabilities thereunder, (xvii) developments relating to our competitors and our industry, (xviii) our ability to achieve the anticipated benefits from the agreements entered into in connection with our partnership with Advanz Pharma and (xiv) other factors that may impact our financial results. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. Factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the U.S. Securities and Exchange Commission, including the \u201cRisk Factors\u201d contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise. Contacts Investors: Maeve Conneighton / Andrew Vulis 212-600-1902 appliedtherapeutics@argotpartners.com Media: media@appliedtherapeutics.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-20T12:00:00+00:00", "sentiment": {"score": 0.11037532426416874, "confidence": 0.12663334608078003, "probabilities": {"positive": 0.12663334608078003, "negative": 0.01625802181661129, "neutral": 0.8571086525917053}}, "embedding": [-0.12988543510437012, -0.11438482999801636, 0.012090477161109447, -0.1304938793182373, 0.022911671549081802, -0.06444425880908966, 0.011684476397931576, 0.18420593440532684, 0.1262502521276474, 0.03383297845721245, -0.07830807566642761, 0.1108890101313591, 0.005425623618066311, 0.05623126029968262, 0.005867720581591129, 0.06243368983268738, 0.02769371122121811, 0.05532797425985336, -0.16077734529972076, -0.018582791090011597, -0.05727114528417587, -0.03963151574134827, -0.02184627577662468, -0.0748094767332077, -0.07625170797109604, -0.015212543308734894, -0.06307438760995865, 0.020242314785718918, -0.12118902802467346, -0.05054083466529846, 0.09516768157482147, 0.09033125638961792, 0.0012192078866064548, -0.08197732269763947, -0.027835838496685028, 0.11795258522033691, -0.1331995725631714, 0.030409807339310646, -0.007898390293121338, -0.02557509019970894, 0.0196695514023304, -0.059425994753837585, -0.11609142273664474, -0.05145437270402908, 0.05002360790967941, -0.23644982278347015, 0.013601655140519142, -0.08552375435829163, -0.01559047307819128, 0.030601205304265022, -0.11182669550180435, -0.08751248568296432, 0.06127845495939255, -0.006149548105895519, -0.036333322525024414, 0.04478880763053894, -0.06899338215589523, -0.06159444525837898, -0.036391787230968475, -0.04219569265842438, -0.05245094746351242, -0.01219192799180746, 0.010312188416719437, 0.06904187798500061, 0.05007447302341461, -0.040710680186748505, 0.07349444925785065, -0.06436183303594589, -0.0019306717440485954, -0.054617997258901596, 0.07255522161722183, -0.045317891985177994, -0.03893382102251053, 0.019480496644973755, 0.025985687971115112, 0.06497462838888168, 0.0033591706305742264, 0.20248183608055115, 0.15615743398666382, -0.08198033273220062, 0.1845448613166809, -0.016602331772446632, 0.011720089241862297, 0.04654944688081741, -0.10134036839008331, 0.06751927733421326, -0.02947716787457466, 0.050620775669813156, 0.013853894546627998, 0.06607790291309357, 0.12675198912620544, 0.011099728755652905, 0.01209279615432024, 0.031129736453294754, -0.02490754798054695, 0.020777462050318718, -0.02567388489842415, 0.010428874753415585, -0.01198501791805029, 0.07351479679346085, -0.060859933495521545, 0.03313826024532318, -0.09006156027317047, -0.060191355645656586, -0.05065501853823662, -0.168404221534729, 0.05237764120101929, 0.03516518697142601, 0.08856886625289917, -0.021276729181408882, -0.09988962113857269, -0.007868390530347824, -0.0633290559053421, 0.01981855183839798, -0.11075738072395325, 0.08273253589868546, -0.06301399320363998, -0.0010904730297625065, 0.09484698623418808, -0.0791727602481842, 0.05769792199134827, 0.1419694870710373, -0.03533901274204254, -0.014514035545289516, 0.04545703902840614, 0.11550521105527878, -0.1279291808605194, 9.914465390984696e-33, 0.03447253257036209, 0.06761154532432556, 0.1070813238620758, 0.09581427276134491, -0.03331848606467247, 0.07076286524534225, 0.0688551813364029, -0.09700380265712738, -0.08149350434541702, -0.12145572155714035, -0.11178417503833771, 0.08121219277381897, -0.0017886238638311625, -0.04880803823471069, -0.19495542347431183, -0.10221895575523376, -0.03182588517665863, -0.018571285530924797, -0.043980084359645844, -0.05019298940896988, 0.05584600195288658, 0.08851523697376251, -0.10783132165670395, 0.05529579147696495, -0.029678907245397568, 0.06906042993068695, -0.08699759095907211, 0.030930012464523315, 0.09551255404949188, 0.07366060465574265, -0.08217866718769073, -0.004399505909532309, -0.07425126433372498, -0.06093734875321388, -0.009608215652406216, -0.08757459372282028, -0.10406427085399628, -0.11312001943588257, 0.0427834577858448, -0.03442468121647835, -0.05496373027563095, 0.0776413083076477, -0.096370168030262, -0.03571392595767975, -0.05334894359111786, 0.0010461760684847832, -0.05614941567182541, 0.033046066761016846, 0.06445042043924332, 0.0013243025168776512, -0.035673074424266815, 0.010324578732252121, 0.13569404184818268, -0.08094661682844162, -0.02327914722263813, -0.0009008492343127728, -0.059079304337501526, 0.011340903118252754, 0.10250148177146912, 0.12708285450935364, -0.03591829165816307, 0.1541849672794342, -0.1284426748752594, 0.13407708704471588, -0.007860535755753517, -0.009694807231426239, -0.0059919655323028564, -0.06781530380249023, -0.031238839030265808, 0.18712058663368225, -0.0028191800229251385, 0.017621366307139397, 0.1094609871506691, 0.04713559150695801, 0.04651002585887909, -0.1010417491197586, 0.04910808801651001, 0.1201842874288559, -0.1160065308213234, 0.06079079583287239, 0.0048342072404921055, 0.028634894639253616, -0.051687873899936676, 0.06225802004337311, 0.029576629400253296, -0.0718533843755722, -0.023148883134126663, -0.06874185055494308, -0.018524998798966408, 0.057295918464660645, 0.04720716178417206, -0.07731064409017563, 0.003539362922310829, 0.19125360250473022, -0.009489865973591805, -1.1135696022945571e-32, -0.009143478237092495, 0.005967938341200352, 0.07609902322292328, -0.03713294118642807, 0.07949550449848175, 0.0063234856352210045, 0.08802111446857452, -0.07596263289451599, 0.16002172231674194, -0.11849009245634079, 0.06839749962091446, 0.10053189098834991, -0.0053545404225587845, -0.014261260628700256, -0.1614188551902771, 0.08544783294200897, 0.045407261699438095, -0.07664515823125839, -0.09999248385429382, 0.042644187808036804, 0.02660844288766384, 0.23119594156742096, -0.06951732188463211, 0.08764469623565674, 0.009541218169033527, 0.003178684040904045, 0.13499125838279724, 0.08496548235416412, -0.00423128716647625, -0.025911269709467888, -0.07302648574113846, -0.05122382566332817, -0.2009659707546234, 0.02569548971951008, -0.05149579048156738, -0.06001589074730873, -0.0006035147234797478, -0.05495910719037056, 0.04541090130805969, 0.0112233841791749, 0.12363488227128983, -0.06488461047410965, -0.017459318041801453, 0.09133276343345642, 0.06743929535150528, 0.04904681816697121, -0.03470926359295845, -0.0732240229845047, 0.002871949225664139, 0.010460397228598595, -0.17612795531749725, 0.041766222566366196, -0.03962824121117592, 0.029834281653165817, 0.0937514528632164, -0.012996666133403778, 0.12117631733417511, 0.004412503447383642, -0.035870879888534546, 0.0008310088887810707, 0.01049969531595707, 0.0960254818201065, 0.08397029340267181, 0.025467442348599434, -0.004268195480108261, 0.17113059759140015, 0.06894825398921967, -0.07323203235864639, -0.02549256570637226, -0.13316823542118073, 0.006351824849843979, -0.1119033619761467, -0.03753543645143509, -0.11527885496616364, -0.024555504322052002, 0.04537642374634743, -0.10147003829479218, -0.18726859986782074, -0.17444270849227905, -0.0338241346180439, 0.005096481181681156, -0.09070496261119843, -0.044073909521102905, -0.04396257549524307, 0.028602613136172295, 0.040261924266815186, 0.05483214557170868, -0.047063518315553665, 0.012573440559208393, -0.06257675588130951, 0.029651682823896408, -0.14153331518173218, -0.02541397698223591, 0.0792427659034729, -0.0017501097172498703, -1.009238701499271e-07, 0.0045965383760631084, -0.058521781116724014, -0.008807579055428505, -0.027713917195796967, 0.09443582594394684, -0.02192862518131733, -0.012442943640053272, 0.006974065210670233, 0.07154037803411484, 0.14090856909751892, 0.07056526839733124, 0.09593643248081207, -0.11455890536308289, -0.02618039771914482, 0.06735018640756607, 0.01555295754224062, -0.09783293306827545, 0.1131802350282669, -0.09547218680381775, -0.0071801054291427135, -0.1442919373512268, 0.0868179053068161, 0.04389970377087593, 0.023090910166502, 0.11274278163909912, -0.08369305729866028, 0.009966504760086536, -0.09350255131721497, 0.03460538387298584, -0.04438714683055878, 0.00033771886955946684, 0.058272261172533035, 0.020618580281734467, 0.11884665489196777, -0.1349075734615326, -0.14316949248313904, 0.04420514777302742, 0.04560200870037079, 0.04403321444988251, 0.09475056082010269, -0.054014869034290314, 0.05411149561405182, 0.025876909494400024, 0.011257348582148552, -0.1085616871714592, -0.03249711915850639, -0.04774363338947296, 0.05135685205459595, 0.08539251983165741, -0.07377994060516357, 0.044908251613378525, -0.001275829505175352, 0.046582505106925964, -0.02734287455677986, 0.012672575190663338, 0.07894890010356903, -0.016865182667970657, -0.03200171887874603, -0.06684821099042892, -0.09607204794883728, 0.013683103024959564, -0.14287027716636658, 0.18722590804100037, 0.048905231058597565], "changes": {"1wk": 0.7954578551132996, "1mo": -25.795454468485733}}, {"text": "Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data Vandana Singh Sat, Dec 21, 2024, 1:15 AM 2 min read In This Article: APLT -4.09% Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data Adrian Alexandru, representing all similarly affected investors, has filed a federal securities class-action lawsuit against Applied Therapeutics (NASDAQ: APLT ), alleging the company violated federal securities laws . The lawsuit claims that the company provided misleading information about its clinical trials and failed to disclose key adverse facts, causing significant financial losses for shareholders. Also Read: Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside The class action covers investors who purchased Applied Therapeutics securities between January 3, 2024, and December 2, 2024. Central to the lawsuit are claims that the company touted positive results from its Phase 3 INSPIRE trial for govorestat for Galactosemia, without disclosing significant issues . Bloomberg Law published a copy of the lawsuit online. Allegations include problems with electronic data capture and dosing errors during the dose-escalation phase of the study, which were concealed from investors. Investor confidence began to erode on November 27, 2024, when Applied Therapeutics received an FDA Complete Response Letter (CRL). The CRL indicated that the agency could not approve the company's New Drug Application for govorestat in its current form, citing deficiencies in the clinical application. Following the disclosure, Applied Therapeutics' stock price dropped sharply, which worsened after the company disclosed receiving a warning letter from the FDA on December 2 highlighting unresolved clinical trial issues. The FDA's warning letter pointed to electronic data capture problems and a dosing error that resulted in lower-than-targeted doses for some patients during the trial's early phase. While Applied Therapeutics claims to have addressed these issues through detailed records and prior communications with the agency, investors reacted negatively to the revelations, further eroding the stock's value. The lawsuit seeks to recover damages for investors who purchased shares at artificially inflated prices, alleging that the company's failure to provide accurate and complete information misled the market. On Friday, Applied Therapeutics named John Johnson as executive chairman and announced that Shoshana Shendelman has stepped down as Chair and CEO. The company named Les Funtleyder, Applied Therapeutics' CFO, as the interim CEO . RBC Capital analyst maintains Applied Therapeutics with a Sector Perform, lowering the price target from $4 to $1.5. Story Continues Price Action : APLT stock closed lower by 13.7% to $0.87 on Friday. Read Next: Kroger Launches $5 Billion Accelerated Share Repurchase: Details Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data originally appeared on Benzinga.com \u00a9 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-20T22:15:51+00:00", "sentiment": {"score": -0.9495500372722745, "confidence": 0.9595243334770203, "probabilities": {"positive": 0.00997429620474577, "negative": 0.9595243334770203, "neutral": 0.030501369386911392}}, "embedding": [-0.10288563370704651, -0.011379627510905266, -0.013565018773078918, -0.023578330874443054, -0.007540079299360514, -0.08139094710350037, 0.029640868306159973, 0.23980754613876343, 0.0833253338932991, 0.12780450284481049, 0.041505780071020126, 0.1234966367483139, 0.09023979306221008, -0.08407385647296906, -0.043478257954120636, -0.08002962172031403, 0.10390892624855042, 0.042436983436346054, -0.14431583881378174, 0.15436838567256927, -0.023366469889879227, -0.02839716710150242, -0.008657141588628292, 0.13878051936626434, -0.1390056610107422, 0.0036953650414943695, -0.08141206204891205, -0.0634528398513794, -0.1705186367034912, -0.06181298941373825, 0.013463426381349564, 0.10292671620845795, 0.04737201705574989, -0.003812003880739212, -0.01456435862928629, -0.026388779282569885, -0.07518923282623291, 0.023288078606128693, -0.07397118210792542, 0.0047903237864375114, 0.058991581201553345, -0.08146581053733826, -0.08977732062339783, 0.10761663317680359, 0.060098566114902496, -0.19714175164699554, -0.023171335458755493, 0.034779518842697144, 0.018757175654172897, 0.11174429953098297, -0.20130589604377747, -0.0779903382062912, 0.10105785727500916, 0.013061124831438065, -0.16076692938804626, -0.0691002830862999, -0.03840070962905884, 0.05489090457558632, -0.06552349030971527, 0.07268629968166351, 0.05125286430120468, 0.0014748270623385906, 0.024280259385704994, -0.009120116010308266, 0.15542292594909668, 0.09896373748779297, 0.0509917326271534, -0.08341806381940842, 0.10738340020179749, -0.06380469352006912, 0.24913397431373596, -0.058977968990802765, -0.05147206783294678, 0.06669138371944427, -0.10176341980695724, 0.11977870017290115, -0.01290985569357872, 0.16466811299324036, 0.14368689060211182, -0.09520991891622543, 0.060056425631046295, -0.06330306082963943, 0.02716890349984169, 0.014953083358705044, -0.008024428971111774, -0.039164528250694275, 0.03703390806913376, 0.09157496690750122, -0.00864027626812458, -0.027232814580202103, 0.2181868553161621, -0.058121152222156525, 0.03131099417805672, 0.0001535171177238226, -0.027278931811451912, -0.06982596963644028, -0.062087155878543854, -0.03888195380568504, 0.05723772943019867, 0.05900409072637558, 0.03448512405157089, 0.022041909396648407, -0.18849700689315796, -0.052768632769584656, -0.04094656929373741, -0.13927696645259857, -0.008670327253639698, -0.17625266313552856, -0.012602072209119797, 0.03154541179537773, -0.08475645631551743, 0.05804746598005295, -0.02304781600832939, 0.002303052693605423, -0.06259357929229736, 0.16394491493701935, -0.14432668685913086, 0.050933435559272766, 0.07644221186637878, -0.025148577988147736, 0.061248909682035446, 0.062374431639909744, -0.05281063914299011, -0.053794801235198975, 0.048900678753852844, -0.026166584342718124, -0.07152777165174484, 1.241423420856094e-32, -0.053475573658943176, 0.057608965784311295, 0.05221892148256302, -0.05268310755491257, -0.03732960298657417, -0.04246395826339722, 0.0754762813448906, -0.04874885082244873, -0.07305549085140228, -0.05046224594116211, -0.13651780784130096, 0.0730634480714798, 0.06938844919204712, -0.05920479819178581, -0.16709303855895996, 0.026176467537879944, -0.047790948301553726, 0.00514819985255599, 0.0038047018460929394, -0.019614167511463165, 0.06872090697288513, -0.019138319417834282, -0.042636893689632416, 0.025602390989661217, -0.12282711267471313, 0.13948926329612732, -0.13940411806106567, 0.04141925647854805, 0.07299581170082092, 0.07744219154119492, -0.020731762051582336, -0.03185653313994408, 0.1361241638660431, -0.04137342423200607, 0.0386279821395874, -0.04387912154197693, 0.04797488823533058, -0.07908020913600922, 0.05869097262620926, 0.0694160982966423, -0.02547815442085266, 0.1008448526263237, 0.05027659237384796, -0.004282896872609854, -0.045886073261499405, 0.030094649642705917, -0.17819496989250183, -0.01102765928953886, -0.08004491031169891, 0.026893120259046555, -0.0018944097682833672, 0.038188718259334564, 0.10599583387374878, -0.03581637144088745, -0.04895341023802757, 0.04915899038314819, -0.1171703115105629, -0.15685701370239258, 0.0331805944442749, 0.16661758720874786, 0.12899012863636017, 0.09615492075681686, -0.04685341566801071, -0.032349616289138794, -0.2317202091217041, 0.12258066236972809, -0.023015938699245453, -0.1242160052061081, -0.09889549016952515, 0.11240941286087036, -0.03490382805466652, 0.04271171987056732, 0.10974014550447464, 0.06379605084657669, 0.028778817504644394, -0.14722135663032532, 0.090603768825531, 0.08523835241794586, -0.08240379393100739, -0.058596160262823105, 0.07360011339187622, -0.09916044026613235, 0.012353681027889252, 0.11451108008623123, -0.12578019499778748, -0.09512986242771149, -0.06835845112800598, 0.04570490121841431, -0.12951193749904633, 0.01280031818896532, 0.08821694552898407, -0.002512209117412567, -0.06191983073949814, 0.19889000058174133, 0.02317560836672783, -1.1363193118080055e-32, -0.15275369584560394, -0.018178412690758705, -0.042324893176555634, -0.06416555494070053, 0.011183848604559898, 0.05031392723321915, 0.02082735300064087, -0.012813277542591095, 0.18045315146446228, -0.03955216705799103, 0.025043528527021408, -0.025694021955132484, -0.03771323338150978, -0.04044526070356369, -0.18773959577083588, 0.14254392683506012, 0.003137468360364437, -0.03596603497862816, -0.047481343150138855, 0.013538436964154243, 0.07054223865270615, 0.16074204444885254, -0.09523665904998779, 0.10351543128490448, 0.023214993998408318, 0.06454403698444366, 0.09650436788797379, -0.02184770442545414, 0.11548838019371033, 2.18608183786273e-05, -0.043467409908771515, -0.002329274546355009, -0.2702566385269165, 0.06508147716522217, -0.06177135184407234, -0.04522418603301048, 0.13812121748924255, -0.12146630883216858, -0.05658574402332306, -0.0580512210726738, 0.07631384581327438, 0.06252548843622208, -0.048282939940690994, 0.047881096601486206, 0.09053723514080048, -0.036129988729953766, 0.06704813987016678, 0.007723165675997734, 0.18500977754592896, 0.06390544772148132, 0.012730106711387634, -0.054161105304956436, 0.15319964289665222, 0.12498289346694946, 0.00023125112056732178, -0.055094048380851746, 0.0551527664065361, -0.05937353894114494, -0.11004841327667236, 0.04419781640172005, 0.014067191630601883, 0.05514104291796684, -0.08235855400562286, -0.025367693975567818, -0.010240718722343445, -0.00019835680723190308, 0.01363203302025795, -0.0398523174226284, 0.07093162089586258, -0.06891440600156784, -0.005293156020343304, -0.09219706058502197, 0.0511893667280674, -0.15852147340774536, 0.05558504909276962, 0.18131527304649353, -0.14617520570755005, -0.06072518974542618, -0.21688981354236603, 0.052817512303590775, 0.14534664154052734, -0.005387476179748774, 0.07166039198637009, -0.011940211057662964, 0.04686688259243965, 0.1165718287229538, 0.08857788145542145, -0.022098969668149948, -0.0853886604309082, 0.06823251396417618, -0.04573163017630577, -0.13544337451457977, -0.036393120884895325, 0.15835633873939514, 0.07128937542438507, -1.002883038836444e-07, 0.07829645276069641, -0.014867488294839859, 0.003441576147451997, -0.039118967950344086, 0.08541394770145416, -0.036245036870241165, -0.052536964416503906, 0.0292537622153759, -0.012133087031543255, 0.0008323267102241516, 0.011070288717746735, 0.15394003689289093, -0.2023789882659912, -0.09510471671819687, -0.06945621967315674, -0.005306761711835861, -0.0557217113673687, 0.07927156984806061, -0.053547851741313934, 0.0413290411233902, -0.10641303658485413, 0.01959482952952385, -0.005726863630115986, -0.17108085751533508, 0.09794004261493683, 0.026468656957149506, 0.07005028426647186, 0.0017987117171287537, -0.04832182079553604, 0.05513688921928406, -0.04378427565097809, -0.10015422105789185, 0.06155717372894287, 0.020910091698169708, -0.11044926196336746, -0.0989074558019638, 0.11331228911876678, 0.16557972133159637, 0.01374412514269352, -0.02541971206665039, -0.11683395504951477, 0.05369707569479942, 0.0014782038051635027, 0.02076195366680622, 0.0817527174949646, -0.03700127825140953, -0.17016497254371643, 0.001571783795952797, 0.20322927832603455, -0.08229658752679825, 0.06172781065106392, -0.060739222913980484, -0.0691152960062027, 0.023868395015597343, 0.01607329025864601, 0.08730094134807587, -0.0601014718413353, -0.02141077071428299, -0.1342417299747467, -0.1404702067375183, 0.062372297048568726, -0.12334207445383072, 0.11177321523427963, 0.12834513187408447], "changes": {"1wk": -3.068182972713942, "1mo": -25.795454468485733}}, {"text": "PREMIUM Top Premarket Decliners MT Newswires Mon, Dec 23, 2024, 4:10 PM iLearningEngines (AILE) shares tumbled 36% in recent Monday premarket activity after saying it volun PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-23T13:10:36+00:00", "sentiment": {"score": -0.8192266672849655, "confidence": 0.8430235385894775, "probabilities": {"positive": 0.023796871304512024, "negative": 0.8430235385894775, "neutral": 0.13317953050136566}}, "embedding": [-0.18013900518417358, -0.11105561256408691, 0.07836969941854477, 0.1517222374677658, 0.12124958634376526, -0.05876770243048668, -0.0029356181621551514, 0.13628843426704407, 0.06452392041683197, 0.07391912490129471, 0.02967318333685398, 0.08723170310258865, -0.04794267937541008, -0.07289339601993561, 0.10454972833395004, -0.026222020387649536, -0.004434242844581604, -0.0578342042863369, -0.14843352138996124, -0.03708386793732643, -0.2948243021965027, -0.14642038941383362, -0.13220256567001343, -0.09634604305028915, 0.18438242375850677, -0.04348549619317055, -0.16310076415538788, 0.02147996611893177, 0.026397280395030975, -0.17489391565322876, 0.07575805485248566, -0.08187475055456161, 0.11868271976709366, 0.044618651270866394, -0.0850159302353859, -0.15782487392425537, -0.025348054245114326, -0.18417763710021973, 0.007121589500457048, 0.0025136275216937065, 0.16255295276641846, -0.10025244951248169, -0.16137130558490753, -0.04830208793282509, -0.14059104025363922, 0.09738989919424057, -0.06145252287387848, 0.07987596839666367, 0.04186166450381279, 0.14052893221378326, -0.06022096797823906, -0.052400197833776474, 0.07445678859949112, -0.15704770386219025, -0.08637621253728867, 0.011508431285619736, -0.12327989935874939, -0.16648627817630768, 0.028776558116078377, -0.008329756557941437, 0.13261187076568604, -0.00222908821888268, 0.002437261864542961, 0.05720311403274536, -0.009114593267440796, 0.14091618359088898, 0.16196279227733612, 0.2521737515926361, -0.0007000093464739621, -0.06486430019140244, 0.030901534482836723, 0.01566365547478199, -0.12723703682422638, 0.10455325990915298, 0.008490373380482197, 0.18939639627933502, 0.164861798286438, -0.12084314227104187, 0.07282095402479172, -0.14861340820789337, -0.06608410179615021, -0.01488314289599657, 0.027609342709183693, -0.04238220676779747, -0.07101505249738693, -0.10117616504430771, 0.12690064311027527, -0.09979165345430374, 0.03174563869833946, -0.13831831514835358, 0.22542424499988556, 0.01706118695437908, -0.07801869511604309, 0.08666050434112549, 0.002052677096799016, 0.06819824129343033, -0.13040298223495483, -0.13183212280273438, -0.22765272855758667, 0.1315973997116089, 0.05035202577710152, 0.18674583733081818, -0.08724387735128403, 0.025769183412194252, -0.12144073098897934, -0.26349005103111267, 0.034963540732860565, 0.027488606050610542, 0.010188320651650429, 0.10941100865602493, -0.04776684567332268, -0.03224233165383339, 0.002286147326231003, -0.16383379697799683, -0.009466663934290409, 0.05627034604549408, -0.1466754823923111, 0.098794125020504, 0.11733555048704147, -0.06973221153020859, -0.05167098343372345, 0.2600715160369873, -0.07768283039331436, 0.0446631945669651, 0.015330180525779724, 0.061290111392736435, -0.0699634775519371, 1.6159958712399668e-32, -0.0732833668589592, 0.06954265385866165, 0.003257510019466281, -0.12667427957057953, -0.06926822662353516, -0.01435790490359068, 0.00752919539809227, -0.006467698607593775, -0.04611985757946968, -0.058656081557273865, -0.09027410298585892, 0.07306119054555893, -0.11905347555875778, -0.008019103668630123, 0.010766197927296162, -0.2702849507331848, 0.01229222770780325, 0.041137803345918655, 0.037095922976732254, -0.06265483051538467, 0.013420327566564083, -0.08718910813331604, -0.047617316246032715, -0.046399880200624466, -0.02325321175158024, 0.009713694453239441, 0.10039816051721573, -0.10023186355829239, 0.10659715533256531, 0.15412504971027374, -0.15226781368255615, -0.0190607737749815, -0.011683449149131775, 0.00076662766514346, -0.06798111647367477, 0.15228258073329926, -0.11690767854452133, 0.0003894393739756197, -0.03024926222860813, -0.07759338617324829, -0.058575887233018875, -0.05694885551929474, -0.24639572203159332, -0.03027423284947872, -0.1649821549654007, 0.048384081572294235, 0.0033834620844572783, -0.07243681699037552, 0.09920933097600937, -0.15451885759830475, -0.13613463938236237, 0.04558008909225464, -0.19808603823184967, 0.02038668282330036, 0.011582811363041401, 0.14386071264743805, -0.04023825004696846, -0.09147566556930542, 0.1771056205034256, -0.13702772557735443, 0.17399847507476807, 0.10947104543447495, 0.05420991778373718, -0.014224945567548275, -0.11185168474912643, 0.25426772236824036, -0.01797519624233246, -0.0374077707529068, -0.13935072720050812, 0.12422609329223633, 0.031120741739869118, 0.028928883373737335, 0.002099051373079419, -0.052360087633132935, -0.06055845692753792, 0.11252808570861816, -0.03435705229640007, -0.03481345996260643, 0.21013128757476807, 0.06664169579744339, 0.05537784472107887, -0.06670159101486206, 0.16492676734924316, -0.008985407650470734, 0.1415049284696579, 0.024407515302300453, 0.1304694563150406, 0.0026896020863205194, -0.013659914024174213, 0.10980046540498734, 0.07289870083332062, -0.017131395637989044, -0.03708307817578316, 0.04476263001561165, 0.0002359584905207157, -1.7329162699077117e-32, -0.12067294120788574, 0.04760347306728363, -0.1847713738679886, 0.08137048035860062, -0.09968193620443344, -0.0527602918446064, 0.02236384153366089, 0.2865666449069977, 0.0563085563480854, 0.14288587868213654, 0.004327906761318445, -0.014127532951533794, -0.08512837439775467, -0.09330392628908157, 0.1509854644536972, -0.06710206717252731, 0.21202926337718964, -0.09944435209035873, 0.03490779548883438, 0.07458276301622391, -0.07461201399564743, 0.06309417635202408, -0.07686790823936462, 0.1437886655330658, 0.19635196030139923, -0.04376256465911865, 0.08187437802553177, 0.11147921532392502, 0.0057195634581148624, -0.107935331761837, 0.04877077043056488, 0.024502648040652275, -0.08372803777456284, 0.029381105676293373, 0.011016320437192917, 0.005578845739364624, 0.09826745837926865, 0.029205596074461937, -0.0592072419822216, -0.09326043725013733, 0.0792803093791008, -0.10288039594888687, 0.013075719587504864, 0.08926963061094284, 0.006615303456783295, 0.005642684176564217, -0.040871549397706985, -0.05437267944216728, 0.20382587611675262, -0.02050832286477089, -0.04363564774394035, -0.008006170392036438, 0.11755333095788956, 0.18664725124835968, -0.11611837893724442, 0.10166185349225998, 0.00247173011302948, -0.01589902862906456, -0.1362607777118683, -0.018624113872647285, -0.017111247405409813, 0.16092680394649506, -0.039439551532268524, -0.12792712450027466, -0.004314459394663572, -0.0339481420814991, 0.05581168457865715, -0.07000681012868881, -0.01917966827750206, -0.06502657383680344, 0.19898618757724762, -0.0904063805937767, -0.0455172024667263, -0.37561288475990295, 0.09048760682344437, 0.23260386288166046, -0.030341321602463722, 0.15213799476623535, -0.02818690985441208, -0.06735669821500778, -0.02521405927836895, 0.10870718955993652, -0.04827958345413208, -0.06594531983137131, -0.08066196739673615, -0.024603337049484253, 0.05315205454826355, -0.004729090724140406, -0.05227280780673027, 0.14305154979228973, -0.07888151705265045, -0.18942487239837646, -0.0732710212469101, 0.1481267660856247, -0.020682165399193764, -1.0064079702942763e-07, 0.053844813257455826, -0.10358685255050659, 0.1528283804655075, 0.05498455837368965, 0.14562509953975677, -0.00470220809802413, 0.007777328137308359, 0.11500459909439087, 0.009384366683661938, 0.2511841356754303, 0.011382766999304295, -0.1017988920211792, -0.15515772998332977, -0.08116103708744049, -0.05059411749243736, -0.0738089457154274, -0.11906123161315918, 0.07356535643339157, -0.02293836511671543, -0.14992737770080566, 0.07670560479164124, 0.005473343189805746, 0.2548423111438751, -0.20377349853515625, 0.07603617012500763, 0.03342423960566521, 0.036396149545907974, -0.14107605814933777, 0.032931361347436905, -0.07012692093849182, -0.07570602744817734, 0.02773824892938137, -0.08336994051933289, -0.10007712244987488, 0.07802923768758774, 0.21858525276184082, 0.12467864900827408, 0.013077015988528728, -0.04815436527132988, -0.003997224383056164, -0.06227308511734009, -0.07447613775730133, 0.13607971370220184, 0.04662778973579407, 0.026156453415751457, 0.07145135849714279, -0.1995394229888916, -0.08514820784330368, 0.18301843106746674, -0.14135326445102692, -0.12100987881422043, -0.08268789201974869, 0.10185950994491577, 0.2315993756055832, 0.049031082540750504, 0.07951825112104416, -0.02581108547747135, -0.043207909911870956, -0.16896574199199677, 0.14621011912822723, 0.06713667511940002, -0.20212112367153168, -0.03703858330845833, 0.1836940050125122], "changes": {"1wk": -1.6147634176795218, "1mo": -24.45213568189846}}, {"text": "Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls The Fly Mon, Dec 23, 2024, 5:35 PM 3 min read In This Article: TMO -0.67% Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top Upgrades: H.C. Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with a $20 price target after the company entered into an exclusive license agreement with privately held Biosion. Raymond James upgraded Weyerhaeuser (WY) to Outperform from Market Perform with a $32 price target, citing improving lumber fundamentals and \"deep valuation discount.\" Raymond James upgraded PotlatchDeltic (PCH) to Outperform from Market Perform with a $45 price target. The firm sees a steadily improving backdrop forming for lumber price fundamentals. Piper Sandler upgraded GCM Grosvenor (GCMG) to Overweight from Neutral with a price target of $14, up from $12.50. There has been a \"noticeable shift in sentiment\" in the alternatives space in recent months and Piper does not believe the discounted valuation that GCM Grosvenor is trading at is warranted. Top Downgrades: William Blair downgraded Applied Therapeutics (APLT) to Market Perform from Outperform without a price target. While the management turnover \"was a necessary step in beginning to rebuild the company s reputation and credibility,\" Applied's business update makes it increasingly unclear when it could begin generating revenue given the marketing authorization application in galactosemia was withdrawn and the new drug application in sorbitol dehydrogenase will no longer be submitted in Q1, the firm tells investors in a research note. Jefferies downgraded Mesoblast (MESO) to Hold from Buy with a price target of A$2.30, up from A$1.10. After Mesoblast's recent share price appreciation, the firm downgraded the shares on valuation. BTIG downgraded Innovative Industrial Properties (IIPR) to Neutral from Buy with no price target. The firm cites the company's announcement last week that its largest tenant, multistate operator PharmaCann which accounts for 16.5% of the company's annualized base rent, had failed to pay December rent at its six cultivation facilities. Alliance Global Partners also downgraded Innovative Industrial Properties to Neutral from Buy with a price target of $75, down from $130, following the announcement of PharmaCann defaulting on its rent payment in December. Top Initiations: BofA initiated coverage of Pony AI (PONY) with a Buy rating and $18 price target. BofA likes Pony's proprietary Virtual Driver technology, and believes the Chinese government will continue to have policies for the robotaxi/robotruck industry and to support industry leaders like Pony, against the backdrop of mobility transformation becoming a key area of technology competition between China and the U.S. Scotiabank initiated coverage of Thermo Fisher Scientific (TMO) , Danaher (DHR) , Waters Corporation (WAT) , all with Sector Perform ratings, and price targets of $605, $265 and $430, respectively. The firm's long-term outlook for the life science tools sector \"has been and remains bullish,\" but in the near term, Scotiabank is more neutral on these large cap names given continued end-market uncertainties, particularly with biopharma and China, and, to a lesser extent, any political uncertainties exiting 2024. Brookline initiated coverage of Exelixis (EXEL) with a Buy rating. The firm anticipates Exelixis will continue to develop its commercial drugs, Cabometyx, and Cometriq, while its partner Genentech will continue to develop Cotellic. H.C. Wainwright initiated coverage of enGene (ENGN) with a Buy rating and $25 price target. The firm says the non-muscle invasive bladder cancer treatment landscape is undergoing a renaissance, and enGene's detalimogene \"represents an innovative treatment option.\" H.C. Wainwright initiated coverage of Sanara MedTech (SMTI) with a Buy rating and $50 price target. The medical technology company is focused on the development and commercialization of products and services that improve clinical outcome in the surgical and chronic wound care markets and the company's successful strategy of market penetration and geographic expansion could continue to drive topline growth in the coming quarters, the firm tells investors. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-23T14:35:43+00:00", "sentiment": {"score": 0.8632070645689964, "confidence": 0.9000217914581299, "probabilities": {"positive": 0.9000217914581299, "negative": 0.03681472688913345, "neutral": 0.06316345930099487}}, "embedding": [-0.10095840692520142, -0.12053844332695007, -0.06165352836251259, 0.00765670370310545, -0.009369703941047192, -0.005610848776996136, 0.0005973563529551029, 0.2009526938199997, 0.07194085419178009, 0.0530027337372303, 0.012290209531784058, 0.06004573777318001, -0.058906618505716324, 0.002140684984624386, -0.04221836104989052, -0.003895615227520466, 0.18771305680274963, -0.021524857729673386, -0.17016440629959106, 0.07724739611148834, -0.0746643915772438, -0.038755275309085846, -0.10480703413486481, 0.01638897694647312, 0.03554657846689224, -0.0373225212097168, -0.07215414941310883, 0.011818841099739075, -0.09135716408491135, -0.07353821396827698, -0.038693539798259735, 0.1022055447101593, 0.09612080454826355, -0.06894104182720184, -0.025526851415634155, -0.0393945574760437, -0.05953790247440338, 0.09199421107769012, 0.09468924254179001, -0.009669791907072067, 0.004666230641305447, -0.06037576124072075, -0.13881590962409973, 0.04599207639694214, 0.002278772182762623, -0.1034710630774498, 0.05225575715303421, -0.001580529846251011, 0.01359456405043602, 0.05688165873289108, -0.11564748734235764, -0.01133202388882637, 0.007208491675555706, 0.029576117172837257, -0.06625428795814514, 0.052165158092975616, 0.0015913713723421097, 0.06021944433450699, 0.04440464824438095, -0.10092879086732864, -0.06132452189922333, -0.03904328495264053, -0.012968377210199833, 0.0841597467660904, 0.07039026916027069, -0.051999397575855255, -0.04162256419658661, -0.03333317115902901, -0.013796655461192131, -0.0018540360033512115, 0.1407332420349121, -0.035662345588207245, -0.02661311626434326, -0.1165986955165863, 0.048454008996486664, 0.16616469621658325, 0.1122795045375824, 0.004160989075899124, 0.1600150316953659, -0.10374142229557037, 0.06507140398025513, -0.09710904210805893, -0.03289320319890976, -0.0721842423081398, -0.02591082826256752, -0.05813640356063843, 0.039300575852394104, 0.043198589235544205, 0.08598645776510239, -0.019110923632979393, 0.14171092212200165, -0.05997783690690994, -0.12005849182605743, 0.024647876620292664, 0.007572799921035767, 0.0017865849658846855, -0.08499014377593994, 0.011482302099466324, -0.0014966297894716263, 0.0606205090880394, 0.055847860872745514, 0.0775085911154747, -0.06775116175413132, -0.052375756204128265, -0.06325283646583557, -0.08460463583469391, 0.042837776243686676, 0.029425840824842453, 0.11179456114768982, -0.004326516762375832, -0.11725960671901703, -0.013226129114627838, 0.02661396935582161, -0.07215782254934311, -0.07023446261882782, 0.057057250291109085, -0.024453865364193916, 0.014005759730935097, 0.005189800634980202, -0.005517004057765007, 0.06003209203481674, 0.05226850509643555, -0.03497826308012009, 0.009023956954479218, -0.05070213973522186, 0.03999073803424835, -0.07350064069032669, 1.2349584958001592e-32, -0.04614511877298355, -0.037591077387332916, -0.016609981656074524, -0.08758506178855896, 0.04454093426465988, -0.037071846425533295, -0.017041414976119995, -0.0022824008483439684, -0.06384757161140442, -0.0056213922798633575, -0.021429147571325302, 0.040526606142520905, -0.01654757186770439, -0.0322437584400177, 0.017762407660484314, -0.05920559912919998, -0.059877797961235046, 0.008110829629004002, 0.03193282335996628, 0.019348500296473503, 0.038754940032958984, 0.08248589932918549, -0.12138912081718445, -0.006791936699301004, -0.05909547582268715, 0.08453910797834396, 0.07559990882873535, 0.027586553245782852, -0.044324859976768494, 0.07249210774898529, -0.050344593822956085, 0.007776856422424316, -0.03044632449746132, -0.004820670932531357, -0.054347924888134, -0.052637454122304916, -0.10387254506349564, -0.13002672791481018, 0.06528592854738235, -0.029333040118217468, -0.09897130727767944, 0.10568773746490479, -0.03417487069964409, -0.018772194162011147, 0.037041075527668, -0.0658133327960968, -0.0519348569214344, 0.0561138391494751, -0.029059451073408127, 0.03956025838851929, -0.023660503327846527, 0.019464775919914246, 0.02972078137099743, 0.02676011063158512, -0.11569733917713165, 0.0054968781769275665, -0.062411174178123474, -0.027576223015785217, 0.05911920964717865, 0.06177579611539841, 0.05341169238090515, 0.1966754049062729, -0.06584544479846954, -0.0030953288078308105, -0.12155935168266296, 0.07854636758565903, -0.04550714045763016, -0.014124792069196701, -0.08237506449222565, 0.15965816378593445, -0.005505180452018976, -0.009922677651047707, 0.048312969505786896, -0.0106742512434721, 0.03529733046889305, -0.07282945513725281, 0.015248122625052929, 0.10363712906837463, 0.07069741934537888, -0.08064503967761993, -0.0537523552775383, 0.024672821164131165, -0.002097862306982279, 0.01359799224883318, -0.060733940452337265, -0.13352465629577637, -0.044619619846343994, 0.013957994058728218, -0.04998161643743515, 0.02494356967508793, 0.018183857202529907, -0.02202918939292431, -0.12404393404722214, 0.16019845008850098, 0.050257470458745956, -1.1808493888058554e-32, -0.10835793614387512, 0.04163539782166481, -0.06750065088272095, 0.0664040744304657, -0.06391960382461548, 0.045204415917396545, -0.0016020489856600761, -0.09687820076942444, 0.07098536193370819, -0.09320591390132904, -0.028861429542303085, 0.12237109243869781, -0.04547794535756111, 0.038377560675144196, -0.035586822777986526, 0.02869759500026703, -0.006812965963035822, -0.071983203291893, -0.029592962935566902, -0.07671332359313965, 0.07714797556400299, 0.19186624884605408, -0.16159692406654358, 0.10495279729366302, -0.0042086318135261536, 0.084671750664711, 0.0325651615858078, 0.12593117356300354, 0.029250789433717728, -0.007530786097049713, -0.04351678490638733, -0.0028680115938186646, -0.13343283534049988, 0.06985199451446533, -0.053028203547000885, 0.1017066240310669, 0.07827144116163254, -0.09655751287937164, -0.088657908141613, 0.047018177807331085, 0.12242188304662704, -0.012725891545414925, 0.07672987878322601, 0.026605049148201942, 0.05385152995586395, -0.042699795216321945, 0.0005038888193666935, -0.1129605621099472, 0.1709907054901123, 0.01854904741048813, -0.010677510872483253, 0.07109984755516052, 0.000398772768676281, 0.18921467661857605, -0.07009852677583694, 0.03364806994795799, 0.10444168001413345, -0.0006087410729378462, -0.1048751026391983, -0.018858155235648155, 0.017393773421645164, 0.15587137639522552, 0.05730406194925308, -0.04056446626782417, 0.02049248293042183, 0.1111067533493042, 0.06417044997215271, -0.1136508360505104, 0.011871532537043095, -0.10420514643192291, 0.007393630221486092, -0.00946728978306055, 0.0762566328048706, -0.07961969822645187, 0.04091373085975647, 0.07764854282140732, -0.003099581226706505, -0.07786049693822861, -0.06813738495111465, -0.12201531231403351, -0.05412641912698746, -0.017397603020071983, 0.0575292594730854, 0.028064589947462082, 0.0155593641102314, -0.01811906136572361, -0.00012200698256492615, 0.05937599390745163, -0.045259904116392136, -0.005393030121922493, -0.025304682552814484, -0.11959744989871979, -0.05100619047880173, -0.00043139606714248657, -0.03298964351415634, -1.0072987777220987e-07, -0.06959512829780579, 0.029930654913187027, 0.003043713979423046, 0.054619982838630676, 0.11952909827232361, -0.04398750513792038, -0.02226732298731804, 0.0757228434085846, 0.02611491084098816, 0.1338454931974411, 0.1373606026172638, 0.08074292540550232, -0.07130196690559387, 0.027462348341941833, 0.017627794295549393, 0.038821011781692505, -0.09339667856693268, -0.05965324118733406, -0.0459771454334259, -0.04669728875160217, -0.062395788729190826, 0.05222053453326225, -0.04637410491704941, -0.05739264562726021, 0.05698350816965103, -0.0415000319480896, -0.008972760289907455, 0.03655863553285599, 0.0046465592458844185, 0.06684684008359909, 0.0018061008304357529, 0.04924705997109413, -0.008516194298863411, -0.022221406921744347, 0.07136046141386032, -0.015153083950281143, -0.01933879964053631, 0.09457217901945114, 0.0237574465572834, 0.09109461307525635, -0.060435809195041656, 0.009168129414319992, -0.06937923282384872, 0.035440780222415924, 0.07592952251434326, -0.08727412670850754, -0.17627665400505066, -0.027134813368320465, 0.014429288916289806, -0.1078016608953476, 0.06633996963500977, 0.02817852422595024, 0.013861935585737228, 0.06275373697280884, -0.018303027376532555, -0.007291544694453478, -0.06820957362651825, -0.05701056122779846, -0.107163205742836, 0.004679655656218529, 0.07707957923412323, -0.21744796633720398, 0.021727170795202255, 0.07391897588968277], "changes": {"1wk": -5.997691712121798, "1mo": -27.5663168714972}}, {"text": "PREMIUM Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says MT Newswires Mon, Dec 2, 2024, 8:16 PM 1 min read In This Article: APLT -4.09% Applied Therapeutics (APLT) faces uncertainty after the US Food and Drug Administration rejected the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "APLT", "date": "2024-12-02T17:16:38+00:00", "sentiment": {"score": 0.02696211449801922, "confidence": 0.045641642063856125, "probabilities": {"positive": 0.045641642063856125, "negative": 0.018679527565836906, "neutral": 0.9356788396835327}}, "embedding": [-0.03300496190786362, -0.12775413691997528, -0.051383208483457565, 0.10368447005748749, 0.021886250004172325, -0.10152028501033783, -0.011916275136172771, 0.13751891255378723, 0.06039392948150635, 0.020496705546975136, 0.05116935819387436, 0.13683755695819855, 0.028195912018418312, 0.012537294067442417, -0.05375875160098076, -0.050569791346788406, 0.1628562957048416, -0.12844416499137878, -0.044335342943668365, 0.0782499834895134, 0.0686173364520073, 0.05408279970288277, 0.05880860239267349, 0.060576941817998886, 0.09060521423816681, -0.06630633771419525, -0.2408878207206726, -0.0805070698261261, 0.08306840062141418, -0.06351149827241898, 0.024090537801384926, -0.04941079765558243, 0.17382663488388062, -0.08440491557121277, 0.09675894677639008, -0.1391298919916153, -0.06246266886591911, -0.018812861293554306, -0.136010080575943, 0.022886810824275017, 0.11819462478160858, -0.201642706990242, -0.19227787852287292, 0.2767711281776428, -0.03342102840542793, -0.16362418234348297, -0.12092185020446777, -0.004021191503852606, -0.0891377329826355, 0.16505829989910126, -0.09781679511070251, -0.22653716802597046, 0.05026848986744881, -0.15015874803066254, 0.04825136065483093, -0.06965144723653793, -0.1533920019865036, -0.09873389452695847, -0.030792510136961937, -0.04956352710723877, -0.02338307350873947, 0.02355153299868107, -0.11484403163194656, 0.09495993703603745, 0.09942488372325897, 0.0914958044886589, 0.13107645511627197, -0.08400560170412064, 0.1303940713405609, -0.215144082903862, 0.12581178545951843, -0.08109262585639954, 0.03588690236210823, 0.010927094146609306, 0.08199185132980347, 0.06985211372375488, 0.12175247818231583, 0.013643021695315838, 0.12935905158519745, -0.05112294480204582, 0.1002209410071373, -0.12844091653823853, 0.017146509140729904, 0.02292489819228649, 0.1296861618757248, -0.170698881149292, -0.0746925100684166, 0.05210106074810028, -0.09088195115327835, -0.14541606605052948, 0.23104287683963776, -0.14412418007850647, 0.06519614905118942, 0.1566646844148636, -0.17079763114452362, 0.02972138114273548, -0.13205744326114655, -0.11717426776885986, -0.06357888132333755, 0.031122058629989624, -0.09283990412950516, -0.03848971053957939, -0.1731671392917633, 0.1636047512292862, -0.03322260081768036, -0.13216209411621094, -0.026297662407159805, 0.057597123086452484, 0.12741348147392273, 0.18354476988315582, -0.033583663403987885, 0.05632317066192627, 0.14034825563430786, 0.05535382777452469, -0.19480858743190765, 0.1974051147699356, -0.13579079508781433, 0.020598817616701126, 0.15331876277923584, -0.02833131141960621, -0.089500293135643, 0.10664843022823334, -0.02207322046160698, -0.05972139909863472, 0.05161073058843613, 0.1427803635597229, 0.0121467849239707, 1.124725631431036e-32, 0.05403415486216545, 0.016908686608076096, 0.13309937715530396, -0.10145795345306396, -0.0077745807357132435, 0.055894628167152405, 0.020182324573397636, -0.22158657014369965, 0.0889405608177185, -0.14483267068862915, -0.17382778227329254, 0.11131957918405533, -0.044889360666275024, 0.09643132239580154, -0.10390332341194153, -0.04986128211021423, 0.014251521788537502, 0.07565749436616898, 0.13748420774936676, 0.24004057049751282, 0.0005571590736508369, -0.08530621230602264, -0.044264353811740875, -0.09127131849527359, -0.11172611266374588, 0.21567445993423462, -0.0064469282515347, 0.08277019113302231, 0.24365592002868652, 0.10713320970535278, -0.08412973582744598, -0.04985123500227928, 0.08653896301984787, -0.09702974557876587, 0.10739913582801819, -0.003872369881719351, 0.06191423162817955, -0.03707591071724892, 0.00037417339626699686, -0.1562158316373825, 0.008031249977648258, 0.06338539719581604, -0.024599872529506683, 0.11121048778295517, 0.12424827367067337, 0.024192405864596367, -0.11854565888643265, -0.05072930455207825, -0.17129988968372345, -0.0016832547262310982, -0.04801568016409874, 0.18019016087055206, -0.08959461748600006, 0.033471137285232544, -0.059409044682979584, 0.019219093024730682, -0.1086299940943718, -0.018385328352451324, 0.12491954118013382, -0.051841072738170624, 0.1488879919052124, 0.09068392962217331, -0.016199618577957153, -0.1149696409702301, -0.015420383773744106, 0.21395036578178406, -0.11048104614019394, -0.23241831362247467, -0.24589456617832184, 0.1027495414018631, -0.03541726991534233, -0.016933416947722435, -0.009652101434767246, 0.12406434863805771, -0.035773906856775284, -0.0918048620223999, 0.14197291433811188, 0.15059669315814972, 0.10044845193624496, -0.14514878392219543, 0.0975203588604927, -0.03505692258477211, 0.054644834250211716, 0.11868488788604736, -0.050353340804576874, -0.04998476430773735, -0.0004783353942912072, 0.09589425474405289, -0.03260020539164543, -0.011175788007676601, 0.032181814312934875, 0.07938249409198761, -0.032571643590927124, 0.19752593338489532, 0.010618044063448906, -1.4232716622443326e-32, -0.054241254925727844, -0.09335020184516907, 0.0689387246966362, -0.10151299834251404, 0.014229164458811283, -0.029496407136321068, -0.08533800393342972, 0.05440894141793251, 0.39833831787109375, -0.03278934583067894, 0.11131764203310013, 0.05702919512987137, -0.005132320336997509, -0.05469730496406555, -0.0489615835249424, 0.17397116124629974, -0.008615131489932537, 0.015108749270439148, -0.19250693917274475, 0.09663253277540207, -0.07899777591228485, 0.17159155011177063, -0.15680880844593048, 0.1807049959897995, 0.09072559326887131, -0.02035902813076973, 0.09439817070960999, 0.01789538748562336, 0.0052926926873624325, -0.2906244397163391, -0.06552216410636902, -0.08399654924869537, -0.31522107124328613, -0.088152676820755, -0.11933785676956177, -0.040810443460941315, 0.09404908120632172, 0.026524126529693604, -0.1509920358657837, -0.012668197974562645, 0.07937651872634888, -0.009213465265929699, -0.20217949151992798, 0.03096497803926468, 0.09805082529783249, 0.12286978214979172, 0.03653468191623688, -0.008052319288253784, 0.11139626055955887, -0.09285856783390045, 0.0027857462409883738, -0.05292250216007233, 0.09827708452939987, 0.13544908165931702, -0.006633616518229246, -0.04560127854347229, 0.1439969837665558, -0.015460081398487091, 0.024721039459109306, -0.033164139837026596, 0.026586884632706642, 0.13064569234848022, -0.11749637871980667, -0.16752375662326813, 0.046058010309934616, 0.10225924104452133, 0.09289021790027618, -0.10250304639339447, 0.16979923844337463, -0.06115499883890152, -0.02699916996061802, -0.15184982120990753, -0.20540302991867065, -0.1897406280040741, 0.018448274582624435, 0.1625814288854599, -0.1839541345834732, -0.0631931871175766, -0.07648244500160217, -0.0828763023018837, 0.093543641269207, -0.0393185056746006, 0.03709989786148071, 0.002994506387040019, 0.054846491664648056, 0.01836538128554821, 0.16313987970352173, -0.13862498104572296, -0.07886674255132675, 0.09185316413640976, -0.18795982003211975, -0.1784745752811432, -0.17714521288871765, 0.11698411405086517, 0.03016907535493374, -1.0028485775137597e-07, 0.2379322201013565, -0.02382502518594265, -0.026124367490410805, -0.02885979227721691, 0.10371512919664383, -0.014438061974942684, -0.20254504680633545, -0.04498017951846123, -0.008866988122463226, -0.005106625612825155, 0.026582716032862663, 0.22061234712600708, -0.1297634243965149, -0.053086161613464355, -0.09044049680233002, 0.11203382164239883, 0.04966600239276886, 0.16388940811157227, -0.01921139284968376, -0.05033891275525093, -0.21170350909233093, 0.07007212191820145, 0.06733570992946625, -0.09019685536623001, 0.017984241247177124, -0.0009183652000501752, 0.09697136282920837, 0.053505972027778625, 0.08208461850881577, -0.04263996332883835, 0.0017157605616375804, -0.04395188391208649, 0.06027219071984291, -0.0038099081721156836, -0.14284175634384155, -0.03198186680674553, 0.17398446798324585, -0.010518434457480907, 0.13959534466266632, -0.0020259900484234095, -0.036224596202373505, -0.021102463826537132, 0.0014772991416975856, 0.05358991026878357, -0.0012624985538423061, -0.00457492982968688, -0.07904747873544693, -0.022494245320558548, 0.04227025434374809, 0.06824624538421631, 0.05601564794778824, -0.12508919835090637, -0.03181513026356697, -0.10495716333389282, 0.0016378667205572128, 0.04682518169283867, -0.06298352032899857, -0.23767992854118347, -0.11609216034412384, -0.11040035635232925, 0.2245105504989624, -0.327348917722702, 0.1562218815088272, 0.07330936193466187], "changes": {"1wk": -29.14285659790039, "1mo": -51.08571393149239}}]